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ABSTRACT 
Telomeres, the protective caps at chromosome ends, shorten with age in most human 
cell types, but may be shortened prematurely by DNA damaging agents.  Defective 
telomeres contribute to aging-related diseases and may give rise to genomic alterations 
implicated in carcinogenesis.  Translesion DNA synthesis is a critical cellular 
mechanism that ensures progression of DNA replication forks, most notably, in the face 
of bulky DNA lesions.  Numerous environmental exposures generate bulky lesions, 
such as ultraviolet (UV) light and hexavalent chromium (Cr(VI)).  Translesion synthesis 
polymerase η’s (polη) role in protecting against UV-induced lesions in the genome has 
been extensively documented, but its role at telomeres is unknown.  Additionally, UV-
induced lesions have been shown to form at telomeres.  Chronic inhalation of Cr(VI) 
induces respiratory diseases associated with aging and telomere dysfunction, including 
pulmonary fibrosis and cancers, and our previous work established that Cr(VI) causes 
telomere damage.  However, the mechanism(s) by which environmental genotoxicants 
promote telomere loss and defects is unknown.  We investigated roles for polη in 
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preserving telomeres following acute physical UVC exposure and chronic chemical 
Cr(VI) exposure.  Similar to its role in protecting against UV-induced DNA damage, we 
report that polη protects against cytotoxicity and DNA replication stress caused by 
Cr(VI).  Our study supports a novel role for translesion DNA synthesis in preserving 
telomeres after UVC and Cr(VI) exposure and genotoxic stress.  We uncover a 
mechanism by which environmental genotoxicants alter telomere integrity, and a 
fundamental cellular pathway that preserves telomere function in the face of genotoxic 
replication stress.  Telomere alterations and dysfunction have been shown to impact 
human health.  This research is significant and relevant to public health because 
knowledge gained will be useful for designing intervention therapies that preserve 
telomeres in human populations following exposure to environmental genotoxicants.  
The hope is that preventative measures will inhibit or delay diseases and pathologies 
related to telomere defects.   
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1.0  INTRODUCTION 
1.1 Telomeres 
In 2009 the Nobel Prize for physiology and medicine was awarded to three scientists 
(Elizabeth Blackburn, Carol Greider, and Jack Szostak) for their research that 
uncovered the DNA sequence of telomeres, how telomeres protect the chromosome 
from degradation, and the enzyme telomerase that adds tandem TTAGGG nucleotides 
to the 3’ end of telomeric DNA.  The Nobel Prize represents recognition by the scientific 
and non-scientific community that telomeres have a critical role in aging and disease.  
Telomere structure and function are essential for maintaining genomic stability of each 
cell.  Maintaining telomere integrity is fundamental to cell viability and a key determinant 
in the survival and health of the organism.   
1.1.1 Telomere Structure and Function 
Human telomeres cap chromosome ends with 5-15 kilobases (kb) of repetitive 
sequences (Fig. 1A).  Telomere length is organism dependent.  Laboratory mouse (Mus 
musculus) telomeres far exceed human telomeres in length, averaging 40-50 kb.  These 
tandem repeats protect the genome from shearing and degradation (Friedberg et al., 
2006).  Mammalian telomeres consist of a 3’ G-rich strand and a C-rich 5’ strand.  The 
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G-rich strand has six tandem repeats of 5’ TTAGGG, while the C-rich strand 
compliments it with 5’ CCCTAA sequences.  Telomeres are duplex strands of DNA 
except for the end of the G-rich strand which terminates in a 150-200 nucleotide long 
single-strand overhang (McElligott and Wellinger, 1997).  The G-rich overhang is 
capable of looping backwards onto itself to form a telomeric-loop (t-loop), invading the 
duplex DNA, and annealing to form a displacement-loop (d-loop).  The t-loop and d-loop 
structures were observed in mouse models and human cells (Griffith et al., 1999) and 
may only be present on a small percentage of telomeres, yet they illustrate how 
telomeres provide protection against genome instability.  The t-loop transforms the 
double-stranded genome ends from a structure that could otherwise be recognized as 
double-stranded breaks (DSB) (Griffith et al., 1999; Palm and de Lange, 2008) into a 
lasso-like structure that embeds the single strand overhang into the duplex DNA.   
 
Telomeres function to preserve chromosome integrity and regulate the number of 
divisions a cell can undergo.  On one hand, the presence of telomeric tandem repeats 
safeguards chromosomes from loss or degradation of genomic DNA sequences.  On 
the other hand, small portions of telomeric DNA are lost with every cell cycle due to the 
inability to completely replicate the end of the chromosome (Wright and Shay, 2000).  
Shortening of the telomere eventually leads to a critically short telomere and to loss of 
the shelterin protein complex (a binding complex essential for telomere structure), and 
promotes a DNA damage response (DDR) at the telomere.  Telomeres that are not 
protected by the shelterin complex become indistinguishable from DSBs, thereby 
signaling DNA repair pathways called homologous recombination (HR) or non-
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homologous end joining (NHEJ) that can cause telomere end-to-end chromosome 
fusions (Palm and de Lange, 2008; Sabatier et al., 2005; Zou et al., 2009).  Loss of 
telomeres and telomere defects can lead to irreversible cell arrest (called cell 
senescence) or apoptosis (Paeschke et al., 2010).  Worth noting, telomeres also have 
secondary roles in the suppression of transcription for nearby genes (Gottschling et al., 
1990), and they impact DNA replication origins (Ferguson and Fangman, 1992).   
1.1.2 Shelterin Protein Complex 
The duplex and the single stranded DNA (ssDNA) of telomeres are bound by a specific 
complex of six proteins called shelterin; TTAGGG- repeat binding factor 1 (TRF1), 
TRF2, protection of telomeres 1 (POT1), transcriptional repressor/activator protein 
(RAP1), TRF1 interacting protein 2 (TIN2), and POT1 and TIN2 organizing protein 
(TPP1) (Palm and de Lange, 2008; Xin et al., 2008) (Fig. 1B).  Each protein has a 
unique role that contributes to the function of chromosomal end capping.  TRF1 and 
TRF2 bind the duplex region of the telomere.  TRF1 has been found to facilitate 
telomere replication possibly by mediating BLM and RTEL helicase recruitment 
(Martinez et al., 2009; Sfeir et al., 2009).  TRF2 has roles in maintaining the 3’ overhang 
(Zhu et al., 2003).  POT1 binds the single-stranded overhang and regulates access of 
telomerase to the overhang (Lei et al., 2005).  Conversely, TPP1 facilitates recruitment 
of telomerase to the 3’ overhang (Abreu et al., 2010; Latrick and Cech, 2010; Zaug et 
al., 2010).  TIN2 stabilizes the protein complex (Ye et al., 2004).   
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The combined functions of individual shelterin proteins protect telomeres from 
DNA damage repair proteins.  POT1 association with the 3’ overhang is essential for the 
inhibition of ataxia-telangiectasia mutated and Rad3-related (ATR) activation (Denchi 
and de Lange, 2007).  In the absence of POT1, the 3’ overhang is recognized as ssDNA 
which leads to replication protein A- (RPA) mediated recruitment of ATR.  ATR 
activation promotes DNA damage checkpoint activation and causes cell cycle arrest 
(Cortez et al., 2001; Costanzo et al., 2003).  Additionally, ataxia-telangiectasia mutated 
(ATM) is activated at DNA double strand breaks, but is inhibited at telomeres by the 
presence of TRF2 (Denchi and de Lange, 2007).  Therefore, the dismantling of the 
shelterin complex from the telomere renders telomeres vulnerable to inappropriate 
processing by DNA repair mechanisms.  Preventing ATR and ATM activation at the 
telomeres is necessary to protect telomeres from being recognized as DSBs that will 
result in the improper induction of mechanisms such as non-homologous end joining 
(NHEJ) that can cause telomere fusions.   
1.1.3 Telomerase 
Telomerase is a telomere binding ribonucleoprotein that has a role in telomere 
maintenance and cancer biology.  The function of telomerase is conserved in most 
eukaryotes.  The enzyme telomerase is a reverse transcriptase responsible for the 
elongation of the 3’ single-stranded overhang of telomeric DNA (Fig. 1B).  The structure 
of telomerase consists of two subunits; a non-coding RNA molecule, hTERC, that 
functions as the telomeric template during synthesis, and hTERT (telomerase reverse 
transcriptase) responsible for extending the telomere by reverse transcribing the 
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telomeric template.  The hydroxyl group at the extreme end of the 3’ overhang is 
recognized by telomerase and extends DNA in the 5’-to-3’ direction.  Telomerase RNA 
includes a CAB-box motif that facilitates binding with Cajal bodies, which enrich and 
facilitate telomerase association with the telomeres in S-phase (Cristofari et al., 2007; 
Jady et al., 2006; Tomlinson et al., 2006).  Tcab1 operates at the CAB-box motif 
mediating telomerase recruitment to the 3’ hydroxyl group of telomeric DNA (Venteicher 
et al., 2009).   
 
While germ cells express telomerase, normal somatic and adult stem cells do not 
express enough telomerase to effectively maintain telomere length (Harley et al., 1990).  
Thus, each time the cell undergoes DNA synthesis in S-phase, telomeres lacking 
telomerase will shorten.  Aging is linked to telomere degeneration since critically short 
telomeres promote cell senescence and genome instability (Blasco, 2005). 
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(A) Human telomeres contain duplex DNA and a ssDNA region called the 3’ overhang.  
(B) Shelterin protein complex is comprised of six main proteins.  TRF1 and TRF2 bind 
the telomeres at the double stranded region and POT1 binds the ssDNA overhang.  
Telomerase accesses telomeres through the 3’ hydroxyl group on the end of the 
overhang.  Telomerase constitutes to subunits, TERT and TERC. 
 
Figure 1. Human telomere and human telomere binding proteins. 
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1.1.4 Telomere Replication 
Replication at telomeres is unique in the genome since it involves replication of 
repetitive sequences, generation of the 3’ overhang, and possible structure assembly 
and disassembly of loops.  As a result, the telomere replication machinery requires the 
function of proteins in addition to the conventional replication machinery; BLM, WRN, 
and RTEL helicases, TRF1, and the CST complex (Crabbe et al., 2004; Ding et al., 
2004; Price et al., 2010; Saharia et al., 2010; Sfeir et al., 2009).  The helicase 
involvement during telomere replication is critical.  They function to unfold ternary 
structures called G-quadruplexes (Vannier et al., 2012).  These guanine tetrads form 
when replication takes place at single-stranded G-rich DNA by transiently folding upon 
themselves to form four stranded DNA molecules (Parkinson et al., 2002).  Specialized 
helicases are also believed to be responsible for disassembly of the t-loop structure 
(Griffith et al., 1999).  
 
At chromosome ends, telomeres cannot be replicated in their entirety due to a 
phenomenon known as the end replication problem (Olovnikov, 1971).  Replicative DNA 
polymerases initiate DNA synthesis from an RNA primer on the template.  These 
primers anneal to the template DNA sequences upstream of each initiation site.  DNA 
replication is bidirectional but DNA polymerases are unidirectional and require a 3’ 
hydroxyl group for nucleotide incorporation.  Therefore, when replication proceeds on 
the leading strand in the 3’  5’ direction, DNA synthesis is continuous following 
extension from the 3’ hydroxyl group of the RNA primer.  However, when replication 
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occurs on the opposite lagging strand in the 5’  3’ direction, it requires synthesis of 
small discontinuous daughter strands, known as Okazaki fragments, from multiple RNA 
primers that are later joined by ligase.  When the final RNA primer is removed from the 
extreme end of the lagging DNA strand, a 3’ single strand overhang is left that cannot 
be duplicated.  Since this extreme end cannot be replicated, approximately 50-200 
telomere base pairs are lost with each round of DNA replication (Olovnikov, 1971). 
 
The end replication problem causes telomere shortening, but it does function to 
efficiently restore the 3’overhang on the newly synthesized telomere formed from the 
lagging strand.  The newly synthesized telomere deriving from the leading strand, on 
the other hand, requires a unique process to generate the 3’overhang.  Studies have 
shown that telomere end resection begins by recognition of the telomere end as a 
double-strand break (DSB) by the MRN complex in humans (Longhese et al., 2010).  
Nucleases and helicases then cleave the 5’ strand leaving a 3’ single strand (Mimitou 
and Symington, 2009). 
1.1.5 Telomere Aberrations 
The progressive loss of telomeric repeats or shelterin proteins leads to defective 
telomeres.  Chromosomal Telomere Fluorescent In Situ Hybridization (Telomere FISH) 
is a technique that has been instrumental in identifying several types of defective 
telomeres and in linking telomere aberrations to chromosome instability and 
tumorigenesis (Gollin, 2005; Murnane and Sabatier, 2004; Soler et al., 2005).  Telomere 
loss or critically short telomeres are aberrations caused by cellular aging or by DNA 
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damage to telomeres.  One model is that unrepaired DNA damage at telomeres could 
permanently block replication forks and cause collapse of the forks into a chromosomal 
break.  Telomere doublets are characterized as two telomere foci arranged on one 
chromatid end.  Although the mechanism that results in this phenotype is not clearly 
understood, doublets are associated with unresolved replication stress (Sfeir et al., 
2009).  They are hypothesized to arise from single stranded gaps in the telomeres or 
from fragmented telomeric DNA (Sfeir et al., 2009) representing more than one site of 
activated replication (origin firing).  Telomere fusions are caused by inappropriate NHEJ 
at critically short telomeres (Maser and DePinho, 2004).  In fact, TRF2 inhibition 
promoted NHEJ and resulted in telomere fusions and chromosome end-to-end fusions 
(Smogorzewska et al., 2002).  Telomere fusions are observed as overlapping telomeric 
foci at the ends of either two chromosomes or two sister chromatids.  Unlike telomere 
loss and telomere doublets that arise from replication stress in S-phase, telomere 
fusions are observed after mitosis. 
1.1.6 Telomeres and Human Disease 
Cell division in somatic cells decreases in frequency overtime and cells enter a state of 
replicative senescence (Chretien et al., 2008).  Telomere shortening is the principle 
mechanism responsible for generating replicative senescent cells and can be prevented 
through the expression of telomerase (Bodnar et al., 1998).  Critically short telomeres 
that are not rescued by telomerase or the alternative lengthening of telomeres pathway 
(ALT; an alternate telomere elongation pathway mediated through recombination) will 
ultimately activate the tumor suppressor proteins p53 or pRB, which then trigger the 
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induction of replicative senescence (Campisi and d'Adda di Fagagna, 2007; Feldser and 
Greider, 2007).  In the absence of functional p53 or pRB, critically short telomeres 
promote genomic instability and may ultimately lead to apoptosis or malignant 
transformation (Hemann et al., 2001).  While senescence contributes to aging-related 
diseases and premature aging disorders through the loss of regenerative capacity of 
degeneration in tissues, overriding senescence can lead to carcinogenesis (Campisi, 
2001) 
 
Several genetic disorders and diseases have been associated with defects in 
telomere maintenance or in essential telomere binding proteins.  Accelerated telomere 
shortening due to mutations in telomerase or telomere associated genes leads to a 
spectrum of telomere shortening syndromes including dyskeratosis congenital, aplastic 
anemia, Hoyerall-Hreidarsson syndrome, pulmonary fibrosis and liver disease (reviewed 
in (Blasco, 2005)).  BLM and WRN are RecQ helicases that have critical roles in 
telomere replication (Croteau et al., 2014).  Bloom syndrome (BS) and Werner 
syndrome (WS), are caused by mutations in the genes that encode for helicases BLM 
and WRN, respectively, and both syndromes exhibit accelerated telomere loss.  WS is 
characterized by premature aging (Gray et al., 1997) while BS is most notably 
characterized by short stature and a predisposition to a broad spectrum cancers 
(German, 1995).  Ataxia telangiectasia (AT) leads to severe neurodegeneration and 
accelerated telomere shortening has been associated with the disease (Metcalfe et al., 
1996).  Seckel syndrome and ataxia telangiectasia like disorder (ATLD) have been 
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characterized with DNA repair signaling dysfunction that also includes dysfunctional 
telomere maintenance (Pennarun et al., 2010).   
1.2 Replication Stress 
Replication stress is defined as the slowing or delay of DNA replication fork 
advancement (Zeman and Cimprich, 2014).  Many factors can obstruct the replication 
fork and cause stress.  Typically, the DNA double helix continues to be unwound by 
replicative helicases while the replication machinery is inhibited at a physical obstruction 
on one strand, which then leads to an accumulation of ssDNA (Pacek and Walter, 
2004).  RPA binds ssDNA and prevents it from forming hairpins or other secondary 
structures (Wold, 1997), however, persistent RPA binding to ssDNA activates ATR 
kinase.  ATR is a serine/threonine protein kinase in the phosphatidylinositol 3-kinase-
related kinases (PIKKs) family.  ATR, and its binding protein ATRIP (ATR interacting 
protein) have roles in DNA damage checkpoint activation (Abraham, 2001).  ATR is one 
of the first proteins recruited to sites of replication stress in the DNA damage signaling 
cascade.  ATR phosphorylates various proteins that function in the recovery of stressed 
DNA replication forks and is required for the G2 checkpoint activation (Cortez et al., 
2001).  The mechanism by which ATR arrests cell cycle progression is through 
inactivating Cdc2 (Shechter et al., 2004b) and Cdc7 (Costanzo et al., 2003); two S-
phase kinases that are essential for replication origin firing.  ATR inactivates these 
proteins by phosphorylating Chk1, which in turn phosphorylates Cdc25a and leads to 
the suppression of Cdc2 (Shechter et al., 2004a) and Cdc7 (Costanzo et al., 2003).  
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Once ATR and its downstream substrates have completed their functions and the 
replication stress has been overcome either through DNA repair mechanisms, fork 
rescue, or translesion synthesis, the replication fork can resume DNA synthesis 
(Petermann and Helleday, 2010).   
1.2.1 Consequences of Replication Stress 
Although the cell has multiple mechanisms capable of restoring a stressed replication 
fork, there are circumstances that do not permit successful recovery.  Examples of such 
circumstances include mutated or loss of DDR proteins, or failed DDR signaling or 
restart mechanisms.  Regions on the genome that are difficult to replicate, such as 
common fragile sites (CFS) are more vulnerable to the consequences of replication 
stress (reviewed in (Debatisse et al., 2012)).  Unresolved replication stress can lead to 
fork collapse and chromosome breaks, destabilization of the genome and can ultimately 
lead to disease (Friedberg et al., 2006).  Unreplicated DNA inhibits separation of sister 
chromatids and creates fused chromatid bridges during anaphase (Mankouri et al., 
2013).  The tension of the fused chromatids will cause chromatid breaks through 
displacement of uneven chromosomal arms and will result in chromosomal 
rearrangements and deletions.  It is believed that these abnormal structures are cleaved 
by nucleases in order to avoid more deleterious consequence of fused chromatids 
(Naim et al., 2013).  Several diseases are linked to the inability, or reduced efficiency, to 
resolve replication stress.  Mutations in the genes that encode for ATR or ATRIP cause 
in Seckel syndrome, which is characterized by growth retardation, dwarfism, 
microcephaly, and mental retardation (reviewed in (Zeman and Cimprich, 2014)) 
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1.3 DNA Damage Response (DDR) 
In the interest of genome integrity, the cell has evolved multiple mechanisms to 
recognize and repair damaged DNA.  DNA damage ensues spontaneously from 
endogenous sources such as metabolic processes, and from exogenous genotoxic 
environmental exposures and medically-related treatments including chemotherapeutic 
agents.  DNA damage response (DDR) mechanisms are designed to remove damaged 
regions of the genome or to mitigate the deleterious effects of these regions and restore 
correct DNA sequences or DNA structure (Friedberg et al., 2006).  The mechanisms 
that have been identified can be classified according to their general function.  Excision 
repair mechanisms are employed to remove chemically modified or incorrect bases or 
nucleotides and to restore correct DNA sequences.  These mechanisms include base 
excision repair (BER), nucleotide excision repair (NER), and mismatch repair (MMR).  
Cells that experience breaking in the sugar-phosphate backbone that results in single 
strand breaks or DSBs, will induce homologous recombination repair mechanisms, or 
rejoining mechanisms, such as NHEJ (Friedberg et al., 2006).  Finally, DNA damage 
tolerance mechanisms allow for the persistence of DNA lesions in the genome during 
replication that can then be repaired at a later time point. There are various identified 
tolerance mechanisms which include recombinational repair, replication fork regression, 
and translesion synthesis (TLS). 
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1.3.1 Basic Excision Repair (BER) 
BER is believed to be the most utilized DNA repair mechanism by the cell and targets 
endogenous damage due to reactive oxygen species (ROS) or other metabolites 
(Friedberg et al., 2006).  Enzymes called DNA glycosylases recognize and catalyze 
lesion-specific excision.  An abasic (AP) site is generated and signals removal by AP 
endonucleases that incise or nick the dsDNA via hydrolysis.  Hydrolysis takes places at 
the phosphodiester bond 5’ to the AP site resulting in a 5’ terminal deoxyribose-
phosphate residue.  DNA-deoxyribophosphodiesterase (dRpase) enzymes are activated 
to cleave the 5’ residue paving the way for DNA synthesis to restore the correct 
nucleotides and DNA ligation to seal the nicks. 
1.3.2 Nucleotide Excision Repair (NER) 
NER is one of two mechanisms identified for the excision of UV-induced bulky DNA 
adducts; cyclobutane pyrimidine dimers (CPD) and 6-4 pyrimidine-pyrimidones (6-4 PP) 
(Friedberg et al., 2006).  The multi-step process begins by recognition of the helix 
distortion by XPC-RAD23B.  Once this protein complex binds to the helix, another 
complex, TFIIH, XPA, RPA, and XPG, is signaled to the site in order to create a pre-
incision structure.  This complex of proteins unwinds 25-30 base pairs in the helix 
around the proximity of the lesion.  XPG is then triggered to cleave the DNA at the 3’ 
end of the damage site, while ERCC1-XPF incises at the 5’ end.  The cleaved fragment 
is then freed from the helical structure and a single-stranded gap is generated.  Next, 
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the DNA polymerase holoenzyme synthesizes new DNA to close the gap and DNA 
ligase seals the strands together. 
1.3.3 Mismatch Repair (MMR) 
MMR is signaled into action upon the generation of DNA replication errors such as 
insertions, deletions, mis-incorporation of single bases, and small deletion loops 
(Kolodner and Marsischky, 1999).  It also has a role in assisting HR repair to achieve an 
error-free repair mechanism due to its ability to proofread DNA synthesis.  The MutSα 
complex (MSH2 and MSH6) is responsible for the recognition of mismatched base 
pairs, and can efficiently recognize even a single mismatch replication error (Acharya et 
al., 1996; Genschel et al., 1998).  MMR has evolved the ability to distinguish the parent 
strands from the daughter strands during DNA synthesis.  Studies have observed that 
nicks on the leading DNA strand may serve to provide the signal for the MMR proteins.  
The MutSβ complex (MSH2 an MSH3), then corrects the replication errors.  Next, the 
MutLα complex (MLH1 and PMS2) is recruited to the MutSα complex and they jointly 
excise the region of ssDNA containing the mismatch (Kolodner and Marsischky, 1999).  
DNA polymerase performs new DNA synthesis and DNA ligase seals the helix. 
1.3.4 Homologous Recombination (HR) 
HR is one of two distinct repair mechanisms that responds to DSBs.  First, DNA at the 
broken ends is resected in a 5’  3’ direction (Fig. 2).  Next, the single stranded 3’ ends 
invade neighboring duplex DNA of a homologous sequence, present either in a sister 
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chromatid or a homologous chromosome, resulting in a displacement loop (D-loop).  
MMR proofreads the base pairing between the invading strand and the newly selected 
template sequence, and if significant differences are detected, the process is 
discontinued.  If the sequences are complementary, then DNA polymerases extend the 
invading strand resulting in the formation of a Holliday junction.  If strand invasion 
occurs from both DNA ends, then processing will lead to the formation of two Holliday 
junctions (reviewed in (Friedberg et al., 2006)).  Repair is complete when the Holliday 
junctions are resolved. 
1.3.5 Non-homologous End Joining (NHEJ) 
NHEJ is another mechanism the cell uses to deal with DNA double strand breaks.  The 
greatest difference between NHEJ and HR is that NHEJ does not rely on homologous 
sequences to repair the break.  Therefore, HR is believed to be the more error-free 
mechanism of the two pathways.  NHEJ is the more error-prone method since the 
process is tolerant of DNA deletions (Chu, 1997).  The process begins with the Ku 
complex (Ku70 and Ku86) that binds the two broken ends of the duplex, and 
subsequently recruits DNA-PKcs kinase.  The presence of Ku and DNA-PKcs on each 
end of the break leads to the alignment of the ends.  DNA ligase IV then ligates the 
broken ends together (reviewed in (Bernstein et al., 2002)). 
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When DSB occurs at the DNA helix, the cell attempt to repair the damage.  (A) An 
example of the major steps in the process of homologous recombination (HR).  (B) An 
example of the major steps in the process of non-homologous end joining (NHEJ). 
 
Figure 2. Two mechanisms for double-strand break repair. 
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1.3.6 Translesion Synthesis (TLS) 
TLS is a DNA damage tolerance mechanism (Fig. 3).  Most TLS polymerases are 
members of the Y family of DNA polymerases (Ohmori et al., 2001), which include 
Rev1, Polymerase κ, Polymerase η (polη), and Polymerase ι.  Another important TLS 
polymerase is polymerase ζ, which is a member of the B family of polymerases.  
Different from the aforementioned mechanisms which function to repair damaged DNA, 
TLS bypasses the lesion, leaving it intact on the DNA helix (Friedberg et al., 2006).  TLS 
spares the cell from more deleterious effects that can be caused by unresolved stalled 
replication forks.  Persistent stalled replication forks lead to fork collapse, translocations, 
chromosome aberrations, and cell death.  The precise mechanism of fork collapse into 
a chromosome break is unknown, but possibilities include loss of replisome 
components, nuclease digestion, or replication run-off (Zeman and Cimprich, 2014).  
The disadvantage of TLS compared to accurate DNA damage repair, is that TLS 
polymerases are generally more error-prone than replicative polymerases.  TLS is often 
performed using mutagenic methods of base pair extension opposite the lesion.  
However, polη has efficiently evolved to function in the accurate bypass of UV-dimers 
(McCulloch et al., 2004).   When the replication fork approaches an unrepaired lesion, 
the fork is blocked and unable to continue synthesizing DNA (Fig. 3).  The processivity 
clamp proliferating cell nuclear antigen (PCNA) has a critical role in switching from the 
replicative polymerases to the TLS polymerases (Hoege et al., 2002).  PCNA is 
monoubiquitinated by the catalytic activity of the Rad6-Rad18 complex, which initiates 
damage tolerance through TLS (Stelter and Ulrich, 2003).  However, ubiquitination can 
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continue to polyubiquitination of PCNA thereby promoting a different tolerance pathway 
known as template-switching (Andersen et al., 2008).  In the case of TLS, once the 
polymerases have been switched, the TLS polymerase will incorporate nucleotides 
opposite the lesion and continue DNA synthesis, thereby leaving the lesion intact.  Next, 
PCNA again switches out the TLS polymerase and restores the replication polymerase 
to the fork.  The replication machinery then continues synthesizing DNA. 
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 Translesion synthesis (TLS) is a mechanism by which DNA lesions are bypassed by a 
specialized polymerase in order to allow for continued progression of DNA replication 
fork.  This processes is facilitated by the ubiquitination of PCNA, a DNA clamp that 
responsible for switching the replicative polymerase out and the TLS polymerase into 
position.  The lesion remains unrepaired on the DNA after TLS 
 
Figure 3. Translesion synthesis. 
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1.4 DNA Polymerase η (polη) 
Polη and its yeast homolog Rad30 are highly conserved throughout eukaryotes.  They 
are the most widely studied of the TLS polymerases.  While TLS is often error-prone, 
polη efficiently bypasses cis-syn cyclobutane thymine dimers (McCulloch et al., 2004) 
(Fig. 4), accurately inserting adenines opposite the dimer and extending the primers a 
few nucleotides past the lesion (Masutani et al., 2000; McCulloch et al., 2004).  Polη 
lacks this same efficiency with the other major UV-induced photoproduct, 6-4 PP.  Pol η 
was observed to insert nucleotides opposite the thymines of 6-4 PPs in vitro, but was 
inefficient at bypassing these lesions (Masutani et al., 2000).  Polη is homogenously 
distributed throughout the nucleus before activation but translocates in S-phase to sites 
of stalled replication forks in response to some genotoxic agents (Kannouche et al., 




Thymine dimer cartoon demonstrating a bulky lesion.  UV irradiation generates two 
covalent bonds by reacting two adjacent thymines.  Kinks form as a consequence of 
these bonds and distorts the helix. 
 
Figure 4. Cyclobutane pyrimidine dimers after UV exposure. 
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1.4.1 Regulation of DNA Polymerase η 
Despite polη’s low fidelity of DNA synthesis on undamaged DNA templates, depletion of 
polη through the expression of targeted small interfering RNAs caused an increase in 
spontaneous DNA mutations in human cells that were not treated with any 
genotoxicants (Choi and Pfeifer, 2005).  Mutations to rad30 in S. cerevisiae did not alter 
the spontaneous mutation frequency compared to controls (McDonald et al., 1997; 
Roush et al., 1998).  Furthermore, overexpressing polη did not alter mutagenesis rates 
in human cells, and insignificantly increased mutagenesis rates in S. cerevisiae (King et 
al., 2005; Pavlov et al., 2001).  Collectively, these findings suggest that polη is tighly 
regulated in response to DNA damaged, and had limited access to undamaged DNA 
(Waters et al., 2009).   
 
Ubiquitination affects polη is many important ways.  First, polη interacts with the 
processivity clamp PCNA during TLS.  This interaction takes place at the C-terminal 
PCNA-binding motif called the PNCA-interacting peptide (PIP) box (Kannouche et al., 
2004) and is additionally mediated by polη’s ubiquitin-binding zinc finger (UBZ) domain 
(Parker et al., 2007).  Monoubiquitination of PCNA, strengthens the affinity between 
PCNA and polη.  Although monoubiquitinated PCNA is not required for the recruitment 
of polη to stalled replication forks (Nikolaishvili-Feinberg et al., 2008), it is required for 
the accumulation of polη into nuclear foci (Plosky et al., 2006).  Rad18, an E3 ubiquitin 
ligase, is believed to have a role in the recruitment of polη to stalled replication forks 
(Yuasa et al., 2006).  As in the case of PCNA, polη accumulation into foci is dependent 
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on Rad18 (Yuasa et al., 2006).  Additionally, Rad18 is involved is the 
monoubiquitination of PCNA.  Lastly, there are studies that reported the 
monoubiquitination of polη via the UBZ domain (Bienko et al., 2005; Pabla et al., 2008), 
although the significance of this process is unclear. 
1.4.2 Roles for DNA Polymerase η 
Polη has also been studied in the context of other types of DNA damage and has been 
reported to successfully bypass a spectrum of DNA lesions.  Polη bypasses 7,8-
dihydro-8-oxoguanines rather accurately (Avkin and Livneh, 2002; Haracska et al., 
2000b) and bypasses thymine glycols (Kusumoto et al., 2002), which provides evidence 
for a role in recovery from reactive oxygen species (ROS).  This is significant as 
endogenous ROS is constantly generated during normal cellular functions.  Polη has 
also been shown to function in the bypass of lesions formed from important 
environmental carcinogens such as (+)-trans-anti-benzo[a]pyrene-N2-dG (Zhang et al., 
2000), and O6-methylguanine (Haracska et al., 2000a) and acetylaminofluorene-
guanine adducts (Yuan et al., 2000).  Polη also responds to adducts caused by 
chemotherapeutic agents.  Polη deficient XPV cells are sensitive to cisplatin (Albertella 
et al., 2005; Chen et al., 2006) and oxaliplatin (Vaisman et al., 2000).  While polη has a 
major role in bypass of a variety of genotoxic lesions, the enzyme is error-prone at 
regions of undamaged DNA (Matsuda et al., 2000).  
 
In addition to polη’s function as a TLS polymerase, two additional roles have 
been reported.  First, polη has been found to function in gene conversion events in 
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chicken cells (Kawamoto et al., 2005) and second, polη has been observed to perform 
DNA synthesis from the invading strand of D-loop structures (McIlwraith et al., 2005).  
Polη function at D-loop structures implies a role in recombination.  However, cell lines 
from XPV patients lacking polη do not exhibit a defect in recombination.  Moreover, 
sister chromatid exchanges, which result from recombination, were observed at higher 
frequencies in SV40-transformed XPV cells, arguing against a role for polη in promoting 
recombination (Cleaver et al., 1999). 
 
1.4.3 Xeroderma Pigmentosum Group Variant 
Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder with eight 
variations; XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XPV.  XP was first reported in 
1874 by a professor of dermatology in Vienna named Moriz Kaposi (reviewed in 
((DiGiovanna and Kraemer, 2012).  However, it was not until 1968 when James Cleaver 
first characterized the disorder for the excision repair deficient forms of XP (Cleaver, 
1968) and 1971 when Burk et al. described the TLS deficient form, XPV (XP Variant) 
(Burk et al., 1971).  Finally, the gene mutated in XPV, POLH, was identified in 1999 
(Johnson et al., 1999; Masutani et al., 1999).  Non-melanoma skin cancers occur in XP 
patients 10,000-fold more frequently than the rest of the population, and XP patients 
show a 2,000-fold increase in melanomas (Kraemer et al., 1994).  With the exception of 
XPV, this disorder derives from mutations in genes that encode for proteins that are 
critical for NER.  Mutations in polη causes Xeroderma Pigmentosum group variant 
(XPV) but these patients are proficient in NER (Johnson et al., 1999; Masutani et al., 
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1999).  Patients are characterized by an increased mutation frequency and high rates of 
skin cancers due to UV exposure (Friedberg et al., 2006).  Although NER is active in 
these patients, normal cells utilize both NER and TLS to efficiently recover from UV-
induced lesions.  In the absence of polη, the cell may use another TLS polymerase, 
such as polymerase ι, which is error-prone in the bypass of UV dimers leading to 
increased mutagenesis and carcinogenesis (Tissier et al., 2000).   
1.5 Chromium  
1.5.1 Chromium Overview 
Chromium (Cr) is an abundant, naturally occurring, transition metal that can be found in 
various oxidation states in soil, water, plants, and animals (Barnhart, 1997; Vitale et al., 
1997).  The most common oxidation states are Cr(0), trivalent chromium (Cr(III)), and 
hexavalent chromium (Cr(VI)).  Cr(0) is generally stable and is found in alloy metal 
mixes, such as stainless steel.  However, industrial methods of processing these alloys 
under high temperatures oxidize Cr(0) to Cr(III) and Cr(VI).  Millions of people globally 
are occupationally exposed to Cr or compounds comprised of Cr (Cancer, 1990; 
Registry, 1993).  Industries involving the production and use of the man-made form of 
Cr, Cr(VI), include welding, chrome plating, chrome pigmenting, ferrochrome 
production, and leather tanning (Fishbein, 1981).  Only Cr(VI) is biologically available 
and thus an environmental hazard that causes toxic effects.  Cr(VI) is released into the 
air by the burning of fossil fuels and incineration of industrial and modern electronic 
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waste (ATSDR, 2005; Tsydenova and Bengtsson, 2011).  90,000,000 lbs of Cr(VI) are 
released annually into the environment in the US leading to atmospheric concentrations 
of 0.2 to 9 ng/m3 in rural and residential areas (ATSDR, 2005).  Non-occupational 
exposures to Cr(VI) result from landfills, toxic waste sites, and irresponsible chromate 
industrial contaminations (Reigistry, 2000).   
1.5.2 Adverse Health Effects 
The International Agency for Research on Cancer (IARC) categorizes Cr(VI) as a Group 
1  human carcinogen (IARC, 1990).  The US Environmental Protection Agency (EPA) 
classifies Cr(VI) as a Group A human carcinogen (EPA, 1984).  Routes of exposure due 
to Cr(VI) are through inhalation, ingestion, and to a minimal degree, dermally.  The 
respiratory tract and airway epithelium represent the primary locations of pathology 
upon inhalation exposure.  Elimination of Cr(VI) accounts for less than 50% of the intake 
and it has been shown to bioaccumulate in the lung, liver, bladder, and bone (ATSDR, 
2005).  Health impairments include, pulmonary fibrosis, respiratory disease, and 
damage to the nasal epithelia (ATSDR, 2005). Indeed, potential carcinogenic outcomes 
result from long-term chronic inhalation exposures to the lung, and the degree of 
adverse health effects depends on the length and severity of the exposure (O'Brien et 
al., 2003).  Epidemiological studies that were conducted by the EPA reported a 25% 
increased risk of dying from lung cancer for those people experiencing lifetime 
exposures to Cr(VI) under the permissible exposure limit (PEL) that was in place prior to 
2006 (Gibb et al., 2000b; Park et al., 2004).  Today the OSHA has implemented a new 
limit of 5 μg/m2 of air over 8 h as a time-weighted average (OSHA, 2006).   
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Many studies have investigated the relationship between cumulative Cr(VI) 
exposure and lung cancer risk.  Unfortunately, most of these studies are limited by 
insufficient controls such as inclusion of effects of tobacco smoke, or do not have 
sufficient follow-up periods to efficiently interpret the data.  However, Gibb et al. 
examined lung cancer mortality in a large cohort of chromate production workers in 
Baltimore with an extended follow-up period of 26-32 years (Gibb et al., 2000b).  The 
study included a retrospective assessment of Cr(VI) exposure and tobacco smoking in 
which they controlled for the effects of tobacco smoking using a predicted increased risk 
of lung cancer due to smoking.  Based on this study, the National Institute for 
Occupational Safety and Health (NIOSH) reanalyzed the data to identify an exposure-
response relationship (NIOSH, 2013).  NIOSH identified an increased risk of lung 
cancer death for workers exposed to 1 μg Cr(VI)/m3 (the previous NIOSH 
recommended exposure limit (REL)) over an occupational lifetime.  Six lung cancer 
deaths per 1,000 workers were estimated at 1 μg Cr(VI)/m3 and approximately one lung 
cancer death per 1,000 workers at 0.2 μg Cr(VI)/m3 (NIOSH, 2013).  Importantly, 
epidemiologic studies reported that chromeplating and stainless steel production 
employees developed nasal ulcerations and/or septal perforations and transient 
reductions in lung function at Cr(VI) concentrations ranging from 2 μg/m3 to 20 μg/m3 
(NIOSH, 2013).  The study conducted on the chromate production plant in Baltimore, 
reported that 60% of the cohort was diagnosed with irritated nasal septum or ulcerated 
nasal septum at 20-28 μg Cr(VI)/m3 on average within one month of occupational 
exposure (Gibb et al., 2000a). 
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The experimental Cr(VI) concentrations used in the present research, with the 
exception of the mutagenesis study (Appendix), were based on concentrations that did 
not induce detectable cell death during the exposure times, and concentrations that 
caused increases in telomere aberrations without changes in cytotoxicity in previous 
studies (Liu et al., 2010; Nemec and Barchowsky, 2009).  These concentrations are 
estimated to be significantly lower than the reported Cr(VI) needed to cause irritated or 
ulcerated nasal septum in the Baltimore study after one month of occupational 
exposure, 20 μg Cr(VI)/m3 (Gibb et al., 2000a) (Fig. 5). The mutagenesis experiments 
involved exposing shuttle vector plasmids directly to Cr(VI) in vitro prior to replicating 
these vectors in human cells.  Therefore, significantly higher concentrations were used 
to generate a higher density of adducts within the reporter gene of the shuttle vector 
construct.  The concentrations we chose were based on previous studies (Guttmann et 






Figure 5. Experimental Cr(VI) concentration compared to Cr(VI) concentration that 





1.5.3 Chromium Metabolism 
Chromate, the oxyanion of Cr(VI), is the most common form of Cr(VI).  Chromate is 
different from Cr(III) in that it can pass through the cellular membrane by way of sulfate 
and phosphate anion channels due to structural similarities between Cr(VI) and these 
anions (Alcedo and Wetterhahn, 1990; O'Brien et al., 2003) (Fig. 6).  Cr(VI) rapidly 
enters the cells where it can be reduced readily to a final biological oxidative state of 
Cr(III).  Intracellular reduction occurs mainly through ascorbate (Standeven and 
Wetterhahn, 1991), likely due to its rate and efficiency of mediating reduction 
(DeLoughery et al., 2014; Quievryn et al., 2003).  However, two thiols, glutathione and 
cysteine, can also reduce Cr(VI) (Quievryn et al., 2001; Standeven and Wetterhahn, 
1991; Suzuki and Fukuda, 1990).  Cr(III) is either generated through two-electron 
transfers via ascorbate or a one electron transfer in the case of thiol mediated reduction 
(Connett, 1984; Stearns and Wetterhahn, 1994).  Cr(III) and the intermediate 
metabolites that form during reduction from Cr(VI) are biologically reactive with proteins 
and DNA molecules.   
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Cr(VI), unlike Cr(III), can pass through anion channels and enter the cell where it will be 
reduced to its final form, Cr(III).  The intermediate metabolites do not cause DNA 
damage whereas Cr(III) adducts have been identified in the generation of mutagens and 
replication fork blocks. 
 
Figure 6. Metabolism of Cr(VI) and formation of genotoxic lesions. 
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1.5.4 Chromium-Induced Lesions 
Cr(III) and Cr(V), a transitory intermediate during reduction, are both genotoxic and form 
a spectrum of adducts with macromolecules (Cieslak-Golonka, 1992) and with DNA 
molecules (reviewed in (O'Brien et al., 2003; Zhitkovich, 2005)).  Cr binds to DNA bases 
and the phosphodiester backbone either through covalent bonds or electrostatic 
interactions.  25% of Cr-DNA adducts are believed to be electrostatic (Quievryn et al., 
2002), 40% of Cr-DNA bonds can be reversed through salt washes, and 20% of the 
bonds are removed through chelation (Snow and Xu, 1991) suggesting that the majority 
Cr adducts are robust covalent bonds.  Kinetic characterization of Cr-DNA adduct 
formation was obtained by incubating Cr(III) or Cr(VI) in the presence of reducers, and 
showed that more than half of Cr-DNA bonds were formed within an hour at 37ºC 
(Quievryn et al., 2003; Snow and Xu, 1991).  Cr(VI) reduction produces an array of 
lesions including Cr-DNA base or phosphate adducts, DNA strand breaks, oxidized 
bases, protein-Cr-DNA crosslinks, abasic sites, ascorbate-Cr-DNA adducts, and DNA-
Cr-DNA interstrand crosslinks.  Characterization of the genotoxicity is rather well-
established, yet the ramification of such injury is poorly understood. 
1.6 Ultraviolet Light (UV) 
Natural UV rays come from solar light and are classified as UVA, UVB, and UVC.  The 
wavelengths of all UV irradiation are shorter than visible light but longer than X-rays.  
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UVA ranges from 400-315 nm, UVB ranges from 315-280 nm, and UVC ranges from 
280-100 nm.  UVA and UVB are the two environmentally relevant forms since UVC 
does not reach the earth’s surface but gets absorbed by the ozone and the atmosphere.  
Human skin that is exposed to the sun’s rays responds by increasing the production of 
melanin, which is a protective pigment near the outer layers of the skin.  However, 
intense acute exposure to UV results in cellular radiation damage that is manifested as 
a skin burn.  Intense chronic exposure to UV can lead to melanoma and non-melanoma 
skin cancers (Gilchrest et al., 1999).  
1.6.1 UV-Induced Lesions 
The types of DNA damage induced by UV that contributes to the onset of skin cancer 
have been extensively documented in the literature.  The effectiveness of UVC in 
generating DNA lesions has led to its widespread use for UV photoproduct research.  
Although UVB and UVA are less potent, they are more environmentally relevant 
than UVC (Kuluncsics et al., 1999).  UV generates CPDs, 6-4 PP, single-strand 
breaks (SSB) and alkali-sensitive lesions (Peak et al., 1987).  The production of singlet 
oxygen by UVA and UVB leads significant levels of reactive oxygen species (ROS) 
and 8-oxoguanine (8-oxoG) (Clingen et al., 1995; Douki et al., 1999).  However, UVC 
does not produce singlet oxygen.  CPDs are the most frequent UV-induced lesions 
(Yoon et al., 2000).  CPDs are formed by covalent bonds between various adjacent 
bases (i.e., CC, TC, CT, or TT) (Fig. 4).  Both CPDs and 6-4 PP are mutagenic if left 
unrepaired, and are either removed by NER or bypassed by TLS involving polη.  6-4 
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PPs, however, are repaired quicker than CPDs by NER (Friedberg et al., 2006; Lo et al., 
2005).  Polη is able to readily bypass the CPD thymine–thymine dimer (TT dimer) 
with high efficiency and moderate fidelity (McCulloch et al., 2004). 
1.7 Statement of Problem and Hypothesis 
Telomeres are 5-15 kilobases of duplex TTAGGG/CCCTAA repeats that create 
protective caps at chromosome ends.  A recent study reported only five dysfunctional 
telomeres are required to trigger a cell to senescence (Kaul et al., 2012).  Telomeres 
shorten with age due to cell division and oxidative DNA damage (Blackburn, 2000; von 
Zglinicki, 2002), and critically short telomeres contribute to a variety of aging-related 
diseases, cancers, genetic disorders and pulmonary diseases (Armanios and 
Blackburn, 2012; Calado and Young, 2009).  Telomeres resemble common fragile sites 
in the genome, in that they are prone to replication fork stalling and sensitive to 
replication stress (Sfeir et al., 2009).  Our previous work established that DNA 
replication stress induced by the man-made environmental pollutant, Cr(VI), causes 
telomere loss and aberrations (Liu et al., 2010).  UV and Cr(VI) are two environmentally 
important genotoxic agents that result in the formation of DNA bulky lesions capable of 
impeding DNA replication and causing collapse of the replication fork into chromosomal 
breaks.  Cells have a mechanism for bypassing replication blocking lesions called 
translesion synthesis (TLS).  Studies in S. cerevisiae reported that TLS polymerase η 
accurately bypasses Cr(VI)-induced lesions (O'Brien et al., 2009).  Polη also has an 
established role in the bypass of UV dimers (Masutani et al., 1999).  
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Very little is known regarding how genotoxic agents that induce replication-
blocking lesions affect telomeres.  Previous studies have shown that UV-induced 
lesions occur directly in the telomeres (Rochette and Brash, 2010).  My first aim was to 
test the hypothesis that UV irradiation induces replication stress at telomeres and 
consequentially leads to telomere aberrations.  My second aim was to test the 
hypothesis that TLS polη is required for telomere preservation after the induction of 
environmentally relevant bulky DNA lesions (UV photoproducts and Cr-DNA adducts).   
 
XPV cell lines develop significantly more genomic mutations after UV exposure 
(McGregor et al., 1999), and XPV patients have considerably higher frequencies of skin 
cancer compared to the general population.  Indeed, TLS proficiency is a critical cancer 
prevention mechanism (Kannouche et al., 2001).  Polη’s role in UV-dimer bypass has 
been shown to extend to other genotoxic lesions, which include those produced by 
chemotherapeutics.  My third aim was to test the hypothesis that polη protects against 
global genome replication stress and mutagenesis in human cells induced by the 
environmental hazard Cr(VI).  
1.8 Statement of Public Health Significance 
Telomeres, the protective caps at chromosome ends, are essential for protecting the 
genome.  Defective telomeres contribute to aging-related diseases and can cause 
genomic alterations that drive carcinogenesis.  Translesion synthesis is a critical cellular 
mechanism that ensures progression of DNA replication forks, most notably, in the face 
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of bulky DNA lesions.  Numerous environmental exposures generate bulky lesions, 
such as ultraviolet (UV) light and hexavalent chromium (Cr(VI)).  Translesion synthesis 
polymerase η’s (polη) role is well established in protecting against UV-induced lesions 
that lead to skin carcinomas and melanoma.  Chronic inhalation of Cr(VI) induces 
respiratory diseases associated with aging and telomere dysfunction, including 
pulmonary fibrosis and cancers, and our previous work established that Cr(VI) causes 
telomere damage.  The mechanisms by which environmental genotoxicants promote 
telomere loss and defects are largely unknown, as are the cellular pathways that 
preserve telomeres in the face of genotoxic stress.  We investigated roles for polη in 
preserving telomeres following acute physical UVC exposure and chronic chemical 
Cr(VI) exposure.  Similar to its role in protecting against UV-induced dimers, we report 
that polη protects against cytotoxicity and replication stress caused by Cr(VI).  Our 
study supports a novel role for translesion DNA synthesis in preserving telomeres after 
UVC and Cr(VI) exposure and genotoxic stress.  We uncover a mechanism by which 
environmental genotoxicants alter telomere integrity, and a fundamental cellular 
pathway that preserves telomere function in the face of genotoxic replication stress.  
Telomere alterations have been shown to impact human health.  The public health 
significance is that knowledge gained from our research and findings may ultimately be 
used for designing preventative interventions that preserve healthy telomeres in human 
populations after exposure to environmental genotoxicants.  The hope is that measures 
that preserve telomeres will inhibit or delay the onset of diseases and pathologies that 
are promoted by telomere defects.   
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2.0  POLYMERASE Η SUPPRESSES TELOMERE DEFECTS INDUCED BY DNA 
DAMAGING AGENTS 
2.1 Abstract 
Telomeres at chromosome ends are normally masked from proteins that signal and 
repair DNA double strand breaks (DSBs).  Bulky DNA lesions can cause DSBs if they 
block DNA replication, unless they are bypassed by translesion (TLS) DNA 
polymerases.  Here we investigated roles for TLS polymerase η (polη) in preserving 
telomeres following acute physical UVC exposure and chronic chemical Cr(VI) 
exposure, which both induce blocking lesions.  We report that polη protects against 
cytotoxicity and replication stress caused by Cr(VI), similar to UVC.  Both exposures 
induce ATR kinase and polη accumulation into nuclear foci and localization to individual 
telomeres, consistent with replication fork stalling at DNA lesions.  Polη deficient cells 
exhibited greater numbers of telomeres that co-localized with DSB response proteins 
after exposures.  Furthermore, the genotoxic exposures induced telomere aberrations 
associated with failures in telomere replication that were suppressed by polη.  We 
propose that polη’s ability to bypass bulky DNA lesions at telomeres is critical for proper 
telomere replication following genotoxic exposures.    
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2.2 Introduction 
Human telomeres are 5-15 kb of TTAGGG/CCCTAA tandem repeats at chromosome 
ends.  The protein complex that binds telomeres, shelterin, functions with telomere 
structure to provide a protective cap to chromosome ends (reviewed in (Palm and de 
Lange, 2008)).  Dysfunctional telomeres are recognized as a DNA double strand break 
(DSB), thereby signaling the recruitment of DNA damage signaling and repair proteins 
to the chromosome end (Takai et al., 2003).  Accumulating evidence indicates that 
telomeres are hypersensitive to DNA replication stress induced either by polymerase 
inhibition with aphidicolin, oncogene expression or deficiencies in proteins that stabilize 
stalled replication forks including ATR kinase and specialized DNA helicases (Crabbe et 
al., 2004; McNees et al., 2010; Rizzo et al., 2009; Sfeir et al., 2009; Suram et al., 2012).  
These studies reveal that replication stress in cells leads to telomere aberrations that 
manifest on metaphase chromosomes as multi-telomeric signals at a chromatid end 
(doublet) or a telomere signal free end (telomere loss).  Evidence indicates that stalled 
replication forks can collapse into DNA double strand breaks (DSB) (Zeman and 
Cimprich, 2014), which may be particularly detrimental at telomeres given that DSB 
repair pathways are normally suppressed by telomeric shelterin (Fumagalli et al., 2012; 
Sfeir and de Lange, 2012; Wang et al., 2004).  Recent findings indicate that as few as 
five dysfunctional telomeres are enough to provoke cellular senescence (Kaul et al., 
2012), demonstrating the importance of maintaining telomere integrity 
 
Replication stress can also be induced at specific loci within the genome if the 
replication fork encounters a DNA lesions.  Bulky lesions left unrepaired can block the 
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replication machinery and signal the recruitment of translesion (TLS) DNA polymerases.  
The TLS polymerase extends DNA synthesis across the lesion, and prevents replication 
fork demise, allowing the cell to complete genome replication so the lesion can be 
repaired at a later time (Reviewed in (Sale et al., 2012)).  TLS is a DNA damage 
tolerance mechanism with the caveat that TLS may not always be error-free, and may 
introduce mutations.  DNA polymerase η (polη) is distinguished for its efficiency in 
inserting correct nucleotides opposite UV-induced cis-syn cyclobutane pyrimidine 
dimers (CPD), the most frequent UV photoproducts (Brunk, 1973; Masutani et al., 2000; 
Masutani et al., 1999).  Mutations in the POLH gene, which encodes polη, cause a rare 
autosomal recessive disorder called xeroderma pigmentosum group variant (XPV), 
characterized by sunlight sensitivity and a high incidence of UV-induced skin cancers 
(Masutani et al., 1999).  Cells from XPV donors have normal nucleotide excision repair 
(NER) and can remove UV photoproducts, but exhibit increased UV-induced replication 
stress (Cleaver et al., 1979; Lehmann, 1979), mutagenesis (Wang et al., 2007), and 
chromatid breaks (Cordeiro-Stone et al., 2002).  Homologous recombination (HR) 
serves as an alternative mechanism for bypassing DNA lesions or for repairing 
collapsed replication forks at blocking lesions (Alabert et al., 2009).  However, 
numerous studies indicate that TRF2 and other shelterin factors repress HR repair 
proteins, protecting telomeres from aberrant processing or lengthening by the ALT 
pathway (reviewed in (Palm and de Lange, 2008)).  Additionally, polη is required for 
successful replication at common fragile sites (CFS) (Bergoglio et al., 2013).  Telomeres 
resemble CFS in that they are difficult to replicate and sensitive to aphidicolin (Sfeir et 
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al., 2009).  However, roles for TLS polymerases in telomere preservation remain 
unexamined. 
 
Previous studies show that telomeres are susceptible to genotoxic exposures 
that induce bulky lesions.  Ultraviolet light causes bulky CPDs, which are either repaired 
by NER or bypassed by DNA polη if the lesion stalls replication at the fork.  Telomere 
sequences contain hot spots for UV pyrimidine dimers on both the G-rich and C-rich 
strands (Kruk et al., 1995; Rochette and Brash, 2010).  A recent study reported 
evidence that telomeres are deficient in CPD removal (Rochette and Brash, 2010).  
While UVB exposures of human cells did not alter mean telomere lengths (Rochette and 
Brash, 2010), the impact of UV on individual telomeres is unknown.  Hexavalent 
chromium (Cr(VI)) is another environmental genotoxic agent that induces a spectrum of 
adducts including bulky lesions that are repaired by NER (Reynolds et al., 2004).  
Evidence indicates that Cr(VI) preferentially reacts with guanine runs (Arakawa et al., 
2006), which predicts that telomeres are also susceptible to Cr(VI)-induced lesions.  
Consistent with this, we previously reported that Cr(VI)-induced replication stress 
causes telomere loss and aberrations (Liu et al., 2010).  Furthermore, Cr(VI) exposure 
in Saccharomyces cerevisiae indicate that polη protects against Cr(VI)-induced 
mutagenesis (O'Brien et al., 2009).   
 
In this study, we investigated a role for polη in the preserving telomeres following 
an acute physical (UVC) or chronic chemical (Cr(VI)) exposure that generates bulky 
DNA lesions in telomeric sequences.  We demonstrate that replication stress is induced 
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at the telomeres following these exposures, which also triggered the accumulation of 
polη at telomeric regions.  Furthermore, we demonstrate that these genotoxic 
exposures in cells lacking functional polη cause increased telomere aberrations 
associated with failures in telomere replication.  Thus, we uncovered new evidence that 
a translesion DNA polymerase is necessary to defend telomeres against bulky DNA 
lesions. 
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2.3 Materials and Methods 
2.3.1 Cell Culture and Exposures 
SV40-transformed XP30RO human fibroblasts (XP-V)-pCDNA vector, and pCDNA-polη 
complemented were a generous gift from Alan Lehmann, University of Sussex.  The 
XP30RO cells have a homozygous deletion near to the 5’ end of the polη gene 
contributing to extensive truncation of the pol η protein (Masutani et al., 1999).  U2OS 
cell lines expressing an EGFP-pol η construct were obtained by Fugene® HD 
Transfection Reagent according to the manufacturer’s instructions.  U2OS cells stably 
expressing GFP-ATR were a generous gift from Jiri Lukas.  GFP-polη XPV cells were a 
gift from Alan Lehmann (Gohler et al., 2011).   Cells were cultured in Dulbecco’s 
modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 
penicillin (50 units/ml), and streptomycin (50 units/ml) in humidified chambers with 5% 
CO2 and 20% O2 at 37⁰C.   
 
Telomerase-expressing hTERT-GM02359 cells (a generous gift from Dr. 
Cordiero-Stone, University of North Carolina at Chapel Hill (Cordeiro-Stone et al., 
2002), GM02359, and BJ cells were cultured in Dulbecco’s modified Eagle medium 
(DMEM) supplemented with 15% fetal bovine serum (FBS) and penicillin (50 units/ml), 
and streptomycin (50 units/ml) in humidified chambers with 5% CO2 and 5% O2 at 37⁰C.   
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Cells were exposed to K2Cr2O7 (Sigma-Aldrich, St. Louis, MO) as described previously 
(Liu et al., 2010), for 48 h at indicated concentrations.  Cells were irradiated with 254 nm 
UVC light at 0, 5 and 10 J/m2 UVC with a fluence of 1 J/m2/s as measured with a 
UVX31 meter.  Recovery was conducted in fresh Cr(VI)-free media at 37ºC for specified 
incubation times.  
2.3.2 Cell Survival Assay 
Cellular toxicity was determined by a cell counting assay using the Beckman Coulter™ 
Z1 Coulter® Particle Counter (aperture 100 µm).  Cells were seeded at a density of 1 x 
105 cells per dish in 35-mm culture dishes and incubated for 24 h.  Cells were then 
exposed to either Cr(VI) for 48 h at various concentrations or to UVC at various doses 
as indicated and recovered for 6 h.  Cells were then counted and subcultured at 4 x 104 
cells per 10-cm culture dish.  Following a seven day subculture in Cr(VI)-free media, 
cells were recounted.   
2.3.3 Flow Cytometry 
Cell cycle profiles were obtained using Click-iT® EdU Flow Cytometry Cell Proliferation 
Assay (Life Technologies™) according to manufacturer’s instructions.  Briefly, 2.5 x 105 
cells were seeded in 10-cm culture dishes 24 h prior to exposures.  Cells were exposed 
to either UVC or Cr(VI) as described and incubated with 10 μM Click-iT® EdU 1 h prior 
to harvest for each time point.  Cells were harvested, counted, and then resuspended in 
1% BSA (100 μl/1 X 106 cells).  Next, cells were fixed and stored at 4ºC overnight in an 
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ice slurry.  After cells were permeabilized and incubated with the reaction cocktail, they 
were stained with DAPI for DNA content.  Detection of Click-iT® EdU performed by flow 
cytometry with BD FACSAria II. 
2.3.4 Immunofluorescene-Fluorescence In Situ Hybridization (IF-FISH) 
As previously described (Liu et al., 2010), IF-FISH was performed either immediately 
after Cr(VI) exposure or after 6 h recovery from UVC exposure.  Cells were fixed in 2% 
paraformaldehyde for 15 min followed by permeabilization in 0.2% Triton X-100 for 10 
min.  Cells were then blocked in 1 mg/ml BSA, 3% FBS serum, 0.1% Triton X-100, 1mM 
EDTA (pH 8.0) in PBS for 1 h and immuno-stained with rabbit anti-GFP polyclonal 
antibody (1:400; GeneTex, Irvine, CA), anti-phospho-Histone H2AX (1:500, Millipore), or 
anti-53BP1 (1:500, Cell Signaling Technology).  Next, cells were incubated with either 
Alexa 488-conjugated (Invitrogen, 1:500) goat anti-mouse secondary antibody or Cy5-
conjugated goat anti-mouse (JIR laboratories, Inc., 1:400).  Cells were fixed in 2% 
paraformaldehyde for 5 min and dehydrated in 70%, 95%, 100% ethanol for 5 min each.  
Samples were denatured for 10 min at 80ºC in hybridization solution (70% deionized 
formamide, 10% NEN blocking reagent [Roche], 0.1 M Tris-HCl [pH 7.4], MgCl2 buffer 
[82 mM NaH2PO4, 9 mM citric acid, 20 mM MgCl2], and 0.5 mg/ml Cy3-OO-(CCCTAA)3 
PNA probe (Panagene, South Korea)).  Samples were hybridized for 2 h at room 
temperature and washed twice in 70% deionized formamide and 10 mM Tris-HCl [pH 
7.4].  Samples were counterstained with DAPI and images were acquired with a Nikon 
A1 confocal microscope. 
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2.3.5 Chromosomal Telomere Fluorescent In Situ Hybridization (Telomere FISH) 
Cells were seeded (3 x 105 for Cr(VI)-treated or 8 x 105 for UVC-treated) in 10-cm 
culture dishes 24 h before exposure.  After exposures, cells were treated with 0.05 
μg/ml colcemid (Invitrogen) for 8 h.  As previously described (Liu et al., 2010), Telomere 
FISH was executed on metaphase spreads.  Cells were harvested and incubated with 
75 mM KCl hypotonic buffer for 12 min at 37ºC.  Cells were then fixed and stored in 3:1 
methanol/acetic acid.  Cells were dropped onto slides and set overnight.  Cells were 
then fixed in 4% formaldehyde for 2 min, washed in PBS and incubated with 0.1% 
pepsin in 0.01 N HCl for 10 min at 37ºC.  Cells were fixed, washed, and then 
dehydrated in 70%, 90% and 100% of ethanol for 5 min. Samples were by air-dried and 
then denatured at 80ºC for 3 min in hybridization solution (see IF-FISH).  Samples were 
hybridized for 2 h at room temperature, washed twice for 20 min each with wash 
solution I (70% deionized formamide, 10 mM Tris-HCl [pH 7.4], and 0.01% BSA) and 
three times 15 min each with wash solution II (100 mM Tris-HCl [pH 7.4], 66.7 mM 
NaCl, and 0.1% Tween 20).  Finally, slides were stained with DAPI and mounted with 
coverslips.   
 
A Nikon Ti90 epifluorescence microscope (Nikon Inc., NY) equipped with 
PlanApo 606/1.40 oil immersion objective was used to image metaphase 
chromosomes.  Images were obtained and analyzed with NIS element advanced 
software using the same settings for set of cell lines in each experiment.  A series of z-
stacked images (0.15 mm steps) were acquired for the identification and examination of 
telomere signal free chromosome ends, doublets and aberrations for each metaphase. 
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2.3.6 Statistical Methods 
OriginPro 8 software was employed for all statistical analyses.  Two sample t-test for 
variance was used to determine significance of mean differences between two 
treatments or time points.  One-way ANOVA followed by the Holm-Sidak test for means 
comparison test determined significance of differences among more than two 
treatments or time points.  The statistically significant level was set at p<0.05. 
2.4 Results 
2.4.1 Polymerase η Deficiency Causes Increased Sensitivity to UVC and Cr(VI) 
Exposures 
To test for a potential role for polη in preserving telomeres after genotoxic stress we 
chose to examine previously established and well characterized isogenic cell lines that 
are proficient or deficient for polη.  SV40-transformed XP30RO human fibroblasts 
complemented with a polη expression vector (Wt) or vector alone (XPV) were 
generously provided by Dr. Alan Lehmann (University of Sussex).  We first confirmed 
that XPV cells show increased sensitivity to UVC (Lehmann et al., 1975) (Fig. 7A).  
Following UVC exposures and 6 h recovery, the cells were sub-cultured and recovered 
for 8 days in fresh media, and then counted.  Caffeine is used to override cellular 
checkpoints and is added to enhance UVC sensitivity of XPV cells but not Wt cells, as 
previously shown (Arlett et al., 1975).  Polη deficient cells are also hypersensitive to 
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DNA replication stress induced by hydroxyurea and chemotherapeutic agents, including 
cisplatin and gemcitabine (Chen et al., 2006; de Feraudy et al., 2007; Lehmann et al., 
1975).  We and others showed that Cr(VI) exposure also causes replication stress and 
replication-dependent chromosome breaks (Bridgewater et al., 1994b; Ha et al., 2004; 
Liu et al., 2010; Zecevic et al., 2009).  Therefore, we predicted that polη might similarly 
protect against Cr(VI)-induced cytotoxicity.  Cells were exposed to various 
concentrations of Cr(VI) for 48 h, followed by recovery for 8 days in Cr(VI) free media.  
At 3 µM Cr(VI) exposure, XPV cells exhibited a dramatic increase in sensitivity, 
compared to Wt cells, as indicated by a 42-fold decrease in relative cell number (Fig. 
7B).  Similar results were obtained in primary cell lines from XPV patients (GM02359) 
compared to normal human fibroblasts (BJ) (Fig. 7C and D).  We observed a 5.5-fold 
decrease in XPV cells after 3 µM Cr(VI) and a 13-fold decrease after 5 µM Cr(VI), 
compared to normal BJ cells.  In general, the SV40-transformed cells exhibited greater 
sensitivity to UVC and Cr(VI) compared to the primary cells, likely due to SV40 large T 
antigen suppression of p53 protein, as described previously for UVC (Cleaver et al., 
1999; Cordeiro-Stone et al., 2002).  In conclusion, our results identify a novel role for 
polη in suppressing cytotoxicity following Cr(VI) exposure and suggest that polη TLS 
protects against Cr(VI)-induced replication stress, similar to its role following UVC 
exposures.   
 
Finally, we asked whether telomerase would be protective against genotoxicity in 
the absence of polη.  We obtained telomerase-expressing XPV cells (hTERT-GM02359) 
cells from Dr. Cordiero-Stone (University of North Carolina at Chapel Hill).  We 
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observed that telomerase decreased cell sensitivity at 0.5 and 1 μM Cr(VI) 
concentrations compared to isogenic controls (Fig. 8).  These data suggests that 
telomeres are involved in the increased sensitivity identified in polη deficient cells. 
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 After indicated UVC irradiation and 6 h recovery, or Cr(VI) exposure for 48 h, cells were 
subcultured in medium (without Cr(VI)) for 8 days, and then counted using a Coulter 
counter.  (A) UVC sensitivity of SV40 immortalized XP30RO-derived cells with vector 
alone or expressing polη (Wt) in the presence or absence of 0.38 mM caffeine. (B) 
Cr(VI) exposure sensitivity of SV40 immortalized XP30RO-derived cells with vector or 
expressing polη (Wt). (C) UVC sensitivity of XPV (GM02359) and BJ primary fibroblasts 
exposed with or without 0.38 mM caffeine. (D) Cr(VI) exposure sensitivity of XPV 
(GM02359) and BJ cells. Percent survival was determined by dividing the number of 
cells at each exposure by the number of cells in the untreated sample. Values represent 
the mean ± SE from two to five independent experiments for each survival assay. 
 





After indicated Cr(VI) exposure for 48 h, XPV and telomerase-expressing XPV 
(XPV+Tert) cells were subcultured in Cr(VI)-free medium for 8 days, and then counted 
using a Coulter counter.  Percent survival was determined by dividing the number of 
cells at each exposure by the number of cells in the untreated sample. Values represent 
the mean ± SE from two to two independent experiments.  
 
Figure 8. Analysis of the sensitivity of XPV + Tert cells to Cr(VI). 
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2.4.2 Polymerase η Deficient Cells Show Delayed Recovery from Genotoxic-
Induced Inhibition of DNA Replication 
It is well established that polη deficient cells exhibit a longer UV-induced S-phase delay 
compared to normal cells, due to polη’s essential role in normal resumption of DNA 
replication following UV exposure (Cordeiro-Stone et al., 2002; Lehmann et al., 1975).  
Next, we examined cell cycle profiles to confirm that polη complementation of XP30RO 
protects against UV-induced replication stress, and to test whether polη also 
suppresses Cr(VI)-induced replication stress.  We expected XPV cells would show a 
reduced fraction of DNA replicating cells compared to Wt cells following recovery from 
UVC and Cr(VI) exposures.  We obtained cell cycle profiles by FACs analysis of DNA 
content and identified cells undergoing DNA replication by EdU pulse labeling prior to 
harvesting at each recovery time point.  To ensure data collection was from live cells, 
we simultaneously stained cells with LIVE/DEAD® Fixable dyes to eliminate any dead 
cells (Fig. 9).  After 5 and 10 J/m2 UVC exposures, both polη proficient and deficient 
cells show a reduction in the fraction of EdU positive cells at 6 hours recovery (Fig. 10).  
By 24 hours recovery, Wt cells exposed to 5 J/m2 showed complete recovery of EdU 
positive cells to pre-exposure levels, while those exposed to 10 J/m2 had increased but 
not yet fully recovered. In contrast, for XPV, both UVC exposures induced a greater 
reduction in the fraction of EdU positive cells, compared to Wt cells, at 12 and 24 hours 
recovery.  Our results confirm that polη is essential for normal recovery of DNA 
replication and cell cycle progression after UVC exposure, consistent with previous 
studies (Lehmann et al., 1975) (Fig. 10). 
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Cr(VI) was shown to inhibit DNA replication and cause cell cycle arrest during 
exposure (Ha et al., 2004; Wakeman and Xu, 2006).  To test if polη has a role in 
recovery from Cr(VI)-induced replication stress, we examined the fraction of cells 
replicating DNA at various time points following 48 hours of low levels of Cr(VI).  Wt 
cells exposed to 1 µM Cr(VI) exhibited a similar fraction of EdU positive cells compared 
to untreated cells.  However, following 3 µM Cr(VI) exposure, these cells show a 
reduction in EdU positive cells by 12 hours recovery progressing to greater reduction by 
24 hours.  XPV cells exposed to 1 µM Cr(VI) showed a slight reduction in EdU positive 
cells at 12 hours post-exposure, but recovered to pre-exposure levels by 24 hours 
recovery.  XPV cells exposed to 3 µM Cr(VI) showed fewer EdU positive cells at 0 hour 
recovery compared to untreated cells, and did not recover by 24 hours post-exposure.  
In summary, we observed a greater reduction in cells replicating DNA following low 
levels of Cr(VI) exposure in the absence of polη.  This suggests that translesion 






Cell viability was evaluated of SV40 immortalized XP30RO-derived cells expressing 
polη (Wt) or vector alone (XPV) prior to cell cycle profiling with LIVE/DEAD® Fixable 
Dead Cell Staining Kit. Cells were (A) irradiated with 0, 5, or 10 J/m2 UVC or (B) 
exposed to 0, 1, or 3 µM Cr(VI) for 48 h and then recovery in fresh media for 48 h. 
 








 Cell cycle profiles of SV40 immortalized XP30RO-derived cells expressing polη (Wt) or 
vector alone (XPV). Cells were irradiated with 0, 5, or 10J/m2 UVC or exposed to 0, 1, or 
3 µM Cr(VI) for 48 h and then recovery in fresh media.  Cells were labeled with EdU 1 h 
prior to harvesting at the various recovery time points and analyzed by flow cytometry.   
(A)  Dot plots of G1, S, G2/M phases of the cell cycle show DNA content on the x axis 
and EdU incorporation on the y axis.  (B) Quantitative analysis of percentage of cells 
actively incorporating EdU at the indicated recovery time points.  Values for Cr(VI) 
represent the mean ± SE from two independent experiments. 
 
Figure 10. Cell cycle profiles of Wt and XPV cells after UVC exposure or 
Cr(VI) exposure. 
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2.4.3 UVC and Cr(VI) Exposures Induce ATR Localization to Telomeres 
Having confirmed that UVC and Cr(VI) impact DNA replication, we next asked whether 
these exposures cause replication stress at telomeres.  Slowed or arrested cell cycle 
progression is characteristic of cell cycle checkpoint activation (reviewed in ref. 
(Abraham, 2001)).  Ataxia telangiectasia and Rad3-related kinase protein (ATR) 
activation represents one of the initial signals for S-phase checkpoint activation.  ATR is 
activated by RPA-bound single-stranded DNA (ssDNA) at sites of polymerase stalling 
(Zou and Elledge, 2003).  Previous reports indicate that ATR is activated following UVC 
or Cr(VI) exposures (Despras et al., 2010; Wakeman and Xu, 2006), and that ATR is 
required for telomere maintenance (McNees et al., 2010; Pennarun et al., 2010).  Since 
ATR localization to stressed replication forks is well established (Barr et al., 2003), we 
reasoned that ATR co-localization with telomeric DNA would serve as an indicator of 
replication stress at telomeres.  For this we used the IF-FISH assay to stain telomeric 
DNA in U2OS cells that stably express eGFP-ATR (provided by Dr. Jiri Lukas, 
University of Copenhagen).  Cells irradiated with UVC were recovered for 6 hours 
before processing and imaging by confocal microscopy.  UVC exposures induced a 
dose-dependent increase in ATR foci formation (Fig. 11).  The average ATR foci per cell 
increased two- and three-fold after 5 J/m2 and 10 J/m2 UVC, respectively, compared to 
mock exposure (Fig. 11B).  An average of two to three ATR foci co-localized with 
telomeric DNA after UVC.  
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We then examined whether ATR formed foci after Cr(VI) treatment.  Similar to 
results after UVC, cells treated with Cr(VI) for 48 hours showed concentration-
dependent increases in the amount of ATR foci (Fig. 11C).  We observed a two-fold or 
greater than four-fold increase in ATR foci per cell after 1µM or 3 µM Cr(VI), 
respectively, compared to mock exposures.  On average, one or two ATR foci localized 
to telomeres after 1µM Cr(VI), while greater than four ATR foci co-localized to telomeres 
after 3 µM Cr(VI).  Taken together, these results provide evidence that both UVC and 






 (A) Confocal images of EGFP-ATR U2OS cells exposed to UVC and recovered for six 
hours or exposed to Cr(VI) for 48 hours.  Cells were analyzed via IF-FISH of ATR 
(green) and telomere (red) co-localization (yellow).  Average ATR foci and co-localized 
ATR and telomere foci per cell after indicated UVC dose (B) or Cr(VI) concentration (C). 
The data represent mean ± SE from two experiments and approximately 50 interphase 
cells.  Bars with a symbol of * indicates a significant difference compared to mock 
exposure and between the various exposures, black bars refer to ATR foci, red bars 
refer to ATR + Telomere foci (p<0.05).  Bars, 10 µM. 
 
Figure 11. UVC and Cr(VI) induce replication stress at telomeres. 
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2.4.4 UVC and Cr(VI) Induce Polymerase η Foci Formation and Localization to 
Telomeres 
Polymerase η accumulates in nuclear foci after UVC irradiation at sites of unrepaired 
DNA lesions and stalled replication forks (Kannouche et al., 2001).  To study the 
localization of polη to telomeres after UVC or Cr(VI) treatment, we used SV40-
transformed XP30RO cells that stably express eGFP-Polη (a gift from Dr. Alan 
Lehmann, University of Sussex (Kannouche et al., 2001) and IF-FISH (Fig. 12).  Cells 
were exposed to 0 (mock) or 10 J/m2 UVC and incubated for 6 hours before being 
processed for IF-FISH.  In agreement with previous studies, we confirm that UVC 
increases polη foci formation, and observed a five-fold increase in polη foci per cell 
compared to mock treatment (Fig. 12B).  After 10J/m2 UVC, an average of two polη foci 
co-localized to telomeric regions per cell.  We obtained similar results for UVC-induced 
polη localization to telomeres in telomerase negative human U2OS cells (Fig. 13).  This 
represents the first report of polη localization to telomeres. 
 
Cr(VI) exposures for 48 hours also induced a concentration-dependent increase 
in polη foci formation (Fig. 12C).  We observed a two-fold or three-fold increase in polη 
foci per cell following 1 or 3 μM Cr(VI), respectively, compared to mock treatment.  
Cr(VI) exposures induced between one to two co-localized polη and telomere foci per 
cell. These results indicate that in addition to polη’s established role in responding to 
UVC, polη responds to DNA lesions induced by low level Cr(VI) exposure.  Moreover, 
these results demonstrate polη’s ability to access telomeric DNA after both physical and 
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chemical genotoxic exposures, and suggest that polη responds to stalled replications 





 (A) Confocal images of EGFP-Polη XP30RO cells exposed to UVC and recovered for 6 
h or exposed to Cr(VI) for 48 h.  Cells were analyzed via IF-FISH of polη (green) and 
telomere (red) co-localization (yellow).  Average polη foci and co-localized polη and 
telomere foci per cell after indicated UVC dose (B) or Cr(VI) concentration (C). The data 
represent mean ± SE from two independent experiments and a minimum of 50 
interphase cells. Bars with a symbol of * indicates a significant difference compared to 
mock exposure and between the different exposures (p<0.05). Bars, 10 µM. 
 
Figure 12. UVC and Cr(VI) induce polymerase η localization to telomeres. 
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 (A) Confocal images of EGFP-Polη U2OS cells exposed to UVC and recovered for 6 h.  
Cells were analyzed via IF-FISH of polη (red) and telomere (green) co-localization 
(yellow).  (B) Average polη foci and co-localized polη and telomere foci per cell after 
indicated UVC dose. The data represent mean ± SE from two individual experiments 
and a minimum of 100 interphase cells. Bars with a symbol of * indicates a significant 
difference compared to mock exposure and between the different concentrations, black 
bars refer to Polη foci, red bars refer to Polη + Telomeres (p<0.05). Bars, 10 µM. 
 
Figure 13. UVC induces polymerase η localization to telomeres in U2OS 
cells. 
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2.4.5 Polymerase η Suppresses DNA Damage Signaling at Telomeres 
Stalled replication forks at blocking DNA lesions can collapse into a DNA double strand 
break.  Previous studies show both UVC and Cr(VI) exposure induce chromosome 
breaks that depend on S-phase progression and genome replication (de Feraudy et al., 
2010; Ha et al., 2004; Limoli et al., 2002; Liu et al., 2010; Squires et al., 2004; Zecevic 
et al., 2009).  These studies show proteins that signal a DNA damage response (DDR) 
and DSBs, including phosphorylation of histone H2AX (γH2AX) and p53-binding protein 
1 (53BP1), form foci after UVC and Cr(VI) exposures in a manner that requires S-phase 
progression.  Since polη was shown to suppress γH2AX response after UVC exposures 
(de Feraudy et al., 2010; Limoli et al., 2002), we asked if polη also prevents DDR 
signaling at telomeres following the genotoxic exposures.  Wt or XPV cells were 
exposed to 5 J/m2 UVC and then fixed either 0 or six hours after recovery in fresh 
media.  Six hours was selected based on evidence for S-phase checkpoint activation for 
both agents at this time point (Fig. 10).  Given that γH2AX can also form at non-DSB 
sites (de Feraudy et al., 2010), we identified DDR positive telomeres as foci containing 
triple co-localized γH2AX, 53BP1 and telomeric DNA using the IF-FISH assay and 
confocal microscopy.  We used an unbiased approach of including both small 53BP1 
foci and large 53BP1 bodies (Lukas et al., 2011), but the majority was small foci (data 
not shown).  Both exposures induced 53BP1 foci formation (Fig. 14).  UVC did not 
induce a significant increase in DDR+ telomeres immediately following exposures for 
either cell line (Fig. 15).  However, we observed a 3.3-fold increase in DDR+ telomeres 
at six hours recovery in Wt cells and a larger than 6.8-fold increase in XPV cells, 
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compared to untreated cells (Fig. 15).  At the six hour recovery time point, cells lacking 
polη harbored a two-fold increase in DDR+ telomeres compared to Wt.  Following 48 
hour exposure to 3 μM Cr(VI), Wt cells showed a 2.8- and 3.7-fold increase in DDR+ 
telomeres at zero and six hours recovery, respectively, compared to untreated (Fig. 15).  
Moreover, XPV cells showed a 4.5-fold and 6.5-fold increase in DDR+ telomeres at 0 
and six hours recovery, respectively, compared to untreated. The number of DDR+ 
telomeres was greater in XPV cells compared to Wt at both recovery time points.  The 
difference in quantifiable sites of DNA damage at telomeres between cells proficient and 





SV40 immortalized XP30RO-derived cells expressing polη (Wt) or vector alone (XPV) 
following irradiation with 5 J/m2 UVC and recovered for six hours or exposure to 3 µM 
Cr(VI) for 48 h.  Cells were analyzed via IF-FISH for 53BP1 at 0 or 6 hours recovery for 
average 53BP1 foci per cell after UVC (A) or Cr(VI) (B).  Data represent averages from 
two individual experiments and a minimum of 50 cells. Bars with a symbol of * indicates 
a significant difference compared to mock exposure and between the two 
concentrations (p<0.05). Bars, 10 µM.  Untreated, UT. 
 




SV40 immortalized XP30RO-derived cells expressing polη (Wt) or vector alone (XPV) 
following irradiation with 5 J/m2 UVC or 3 µM Cr(VI) for 48 h. Cells were analyzed via IF-
FISH of 53BP1 (green), γH2AX (magenta), and telomere (red) co-localization (white) at 
0 or 6 hours recovery. (A) Confocal images of untreated Wt cells and Wt and XPV cells 
exposed to UVC or Cr(VI) and recovered for six h.  Average DDR foci and telomere foci 
per cell after 0 or six h recovery from UVC (B) or Cr(VI) (C).  Data represent averages 
from two independent experiments and a minimum of 50 cells. Bars with a symbol of * 
indicates a significant difference compared to mock exposure and between the various 
recovery time points (p<0.05). Bars, 10 µM. Untreated. UT. 
 
Figure 15. UVC and Cr(VI) induce a DNA damage response (DDR) at 
telomeres. 
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2.4.6 Polymerase η Protects Against UVC and Cr(VI) Induced Telomere 
Aberrations 
Having established that polη localizes to telomeres and suppresses DDR signaling at 
telomeres after UVC and Cr(VI) treatments, we next asked whether polη functions in 
preserving telomere structure and integrity following genotoxic exposure.  We previously 
reported that Cr(VI)-induced replication stress leads to telomere aberrations in human 
fibroblasts (Liu et al., 2010).  While exposing human fibroblasts to UVB failed to alter 
mean telomere lengths, the impact on individual telomeres had not been examined 
(Rochette and Brash, 2010).  To examine polη function in preserving telomeres 
structure after the exposures, we prepared and stained chromosome metaphase 
spreads for telomeres by fluorescent in situ hybridization (Telo-FISH) (Fig. 16A).  
Following six hours recovery from UVC exposure, cells were treated with colcemid for 
eight hours to arrest cells in metaphase.  Since this time point coincides with active 
DNA synthesis in the cells that received 5 J/m2 UVC, but not 10 J/m2 (Fig. 10), we 
reasoned that only the lower dose would allow the cells to reach metaphase within the 
experimental time frame.  Interestingly, the mock treated XPV cells exhibited 3.7-fold 
more signal free ends (SFEs) and 2-fold more telomere doublets, compared to mock Wt 
cells (Fig. 16).  This may be related to polη roles in bypass of oxidative damage and/or 
fragile site stability (Bergoglio et al., 2013; Sale et al., 2012).  UVC exposure of Wt cells 
induced a 2-fold increase in telomere aberrations, although averaging less than one 
aberration per metaphase for both telomere losses and doublets (Fig. 16C).  However, 
XPV cells showed a significant increase in telomere losses and doublets (about 3-fold 
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each) after 5 J/m2 when compared to untreated cells.  Additionally, we observed UVC 
induces chromatid breaks in polη deficient cells consistent with previous reports 
(Cordeiro-Stone et al., 2002) and confirming polη’s important role in chromosome 
stability.  Similar results were obtained in primary skin fibroblasts, BJ and XPV 
(GM02359), exposed to 0 and 5 J/m2 UVC (Fig. 17). 
 
We examined telomeres following 1 and 3 µM Cr(VI) since exposures at these 
concentrations revealed cell cycle progression during the recovery period required to 
obtain metaphase cells for chromosomal analysis (Fig. 10).  Colcemid was applied 
immediately following the 48 hours of Cr(VI) exposure.  Similar to UVC, the mock 
treated XPV cells exhibited a higher level of telomere loss and telomere doublets, 
compared to Wt (Fig. 16D).  Cr(VI) exposures induced a concentration dependent 
increase in both telomeres losses and doublets for the Wt cells, although the total 
aberrations per metaphase remain close to one.  Strikingly, we observed a greater 
Cr(VI) induction of telomere aberrations for the XPV cells compared to Wt, in most 
cases.  The 1 µM Cr(VI) exposure of XPV cells induced a six-fold increase in telomere 
losses and a 2.5-fold increase in doublets compared to mock.  The 3 µM Cr(VI) caused 
a 9.5-fold increase in telomere losses and a 4-fold increase in doublets compared to 
mock.  Notably, these two types of aberrations are associated with replication stress, 
while our findings of telomere chromosome or chromatid fusions were less than 0.05 
and 0.25 in fifty metaphases analyzed for 5 J/m2 UVC and 3 μM Cr(VI), respectively, in 
XPV cells (data not shown).  Similar to UVC, we also observed that polη suppressed 
Cr(VI)-induced chromatid breaks illustrating a role for polη at non-telomeric regions 
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following Cr(VI) exposures as well (Fig. 16D).  Our findings are a first account of a role 
for polη in preserving telomere integrity after relatively low levels of UVC or Cr(VI) 
exposure.  The dramatic increase in replication-associated telomere aberrations in cells 
lacking functional polη compared to Wt cells suggests that polη is required for proper 




 (A) Representative metaphase of telomere FISH of untreated Wt cells. (B) 
Representative images of telomere aberrations and chromatid breaks. SFE, signal free 
end. (C) Average telomere defect per metaphase after 0 or 5 J/m2 UVC irradiation, 6 h 
recovery, and 8 h colcemid or (D) 0, 1, or 3 μM Cr(VI) for 48 h and 8 h  colcemid.  Bars 
with * are significantly different (p<0.05).  The data represent mean ± SE from two 
individual experiments with approximately 50 metaphases.  Telomere signal free ends, 
SFE. 
 
Figure 16. UVC and Cr(VI) induce telomere aberrations in XPV cells. 
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(A) BJ and (B) XPV (GM02359) primary fibroblasts exposed to 0 or 5 J/m2 UVC, 
recovered for 6 h, and incubated for 10 h with colcemid.  Analysis of telomere defects 
per metaphase was evaluated using telomere FISH. Bars with * are significantly 
different (p<0.05).  The data represent mean ± SE from an average of two to three 
independent experiments and 75 metaphases.  Telomere signal free ends, SFE. 
 
Figure 17. UVC induces telomere aberrations in BJ and GM02359 cells. 
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2.5 Discussion 
Our findings provide strong evidence that TLS polymerase η gains access to, and 
functions at telomeres, after the induction of bulky DNA lesions.  We uncovered a novel 
role for polη in telomere preservation.  Previous studies have shown that various DNA 
repair pathways are either reduced or suppressed at telomeres (Fumagalli et al., 2012; 
Palm and de Lange, 2008; Rochette and Brash, 2010).  TLS represents a DNA damage 
tolerance pathway that does not repair the damage, but defends the genome against 
consequences of unrepaired DNA lesions.  Polη’s role in TLS prevents stalled 
replication forks from collapsing into DSBs through its ability to bypass DNA lesions 
during replication.  Our data provide new evidence that telomeres rely on lesion bypass 
mechanisms for replication after genotoxic stress, consistent with reports that 
alternative mechanisms of fork recovery including HR and DSB repair are normally 
suppressed at telomeres (Fumagalli et al., 2012; Palm and de Lange, 2008). 
2.5.1 Polη Roles after Cr(VI) Exposure 
Polη’s role in lesion bypass extends beyond UV-induced CPDs to roles in normal 
replication after hydroxyurea (de Feraudy et al., 2007) cisplatin, and gemcitabine (Chen 
et al., 2006).  O’Brien et al. showed that polƞ mediated TLS prevents Cr(VI) induced 
mutations in S. cerevisiae (O'Brien et al., 2009).  Here we report the first evidence that 
polη protects against Cr(VI) exposure in mammalian cells.  Polη deficient human cells 
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exhibited hypersensitivity and increased chromatid breaks (Fig. 7 and 16).  
Furthermore, Cr(VI) induced polη foci formation similar to UVC (Fig. 12).  These data 
suggest that polη functions to bypass Cr(VI) lesions during replication in a similar 
fashion as CPDs.  UV photoproducts are bulky lesions that distort the double helix and 
stall replication forks (Brunk, 1973).  Cr(VI) forms a spectrum of DNA lesions, most of 
which are bulky binary or ternary Cr-DNA adducts bound to the phosphodiester DNA 
backbone (Salnikow and Zhitkovich, 2008) which impede polymerase progression 
(Bridgewater et al., 1994b).  Nucleotide excision repair (NER) removes photoproducts 
(Friedberg, 2001) and Cr-DNA adducts (Reynolds et al., 2004).  Therefore, it is not 
surprising that TLS mechanisms operate at Cr-DNA adducts, similar to UV 
photoproducts to prevent replication fork collapse at unrepaired lesions.   
 
Cell cycle analysis revealed that polη functions in normal recovery from Cr(VI)-
induced replication inhibition (Fig. 10).  Control experiments with UVC confirmed that 
cells lacking polη were delayed in S-phase, based on fewer cells synthesizing DNA 
during recovery compared to Wt cells (Fig. 10) (Cleaver et al., 1979; Gohler et al., 
2011).  The pattern of EdU positive cells differs for Cr(VI) compared to UVC (Fig. 10B), 
and we attribute this to an acute physical versus chronic chemical exposure for UVC 
and Cr(VI), respectively.  At 0 hours recovery, XPV cells exposed to 3 μM Cr(VI) show 
reduced EdU positive cells, whereas reductions were not observed until 6 h recovery 
from UVC.  S-phase checkpoint activation likely occurred during the 48 h Cr(VI) 
exposure, but would require time for replication forks to encounter UV lesions after the 
acute irradiation.  We interpret the reduction in EdU positive XPV cells after Cr(VI) as a 
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Cr(VI)-induced S-phase delay, similar to UVC, because significant cell death did not 
occur during recovery (Fig. 9).  Consistent with this, we observe cell proliferation in both 
Wt and XPV cells eight days post exposure (Fig. 7).  However, the lack of full recovery 
by 24 hours following 3 μM Cr(VI) exposures of XPV cells suggests a fraction of these 
cells remain arrested.   
2.5.2 Evidence that Bulky Lesions Induce Fork Stalling at Telomeres 
UV irradiation and Cr(VI) exposure revealed concentration-dependent increases in ATR 
foci and polη per cell (Fig. 11).  We propose these foci identify sites of replication stress 
at DNA lesions and contribute to signaling the S-phase checkpoint based on previous 
reports.  Blocked replication forks produce ssDNA intermediates provoking RPA-
mediated ATR recruitment during S-phase (Barr et al., 2003; Zou and Elledge, 2003), 
and ATR mediates S-phase checkpoint signaling in response to ssDNA intermediates 
(Zou and Elledge, 2003).  S-phase checkpoint activation inhibits DNA synthesis as cell 
cycle progression pauses to repair the damage, which is consistent with the cell cycle 
profiles following UVC and Cr(VI) exposure (Fig. 10).  The induction of both ATR and 
polη foci at telomeres in response to UVC and Cr(VI) exposures (Fig. 11 and 12) 
suggests that replication forks are stalled at telomeres due to unrepaired lesions 
blocking the forks.  Previous studies show polη translocates to stalled replication forks 
and polη foci overlap with CPD antibody staining (Kannouche et al., 2001).  
Furthermore, CPDs were detected at telomeres following UVC exposures (Kruk et al., 
1995; Rochette and Brash, 2010), our unpublished data).  Although the foci counts are 
low per cell for both ATR and polη at telomeres, we believe they are significant.  
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Confocal microscopy displays one plane of focus of the nucleus where on average 20 
telomere foci are visible in our images.  Of these foci, about 14% co-localized with polη 
foci after 10 J/m2 UVC and 9% co-localized with polη foci after 3 μM Cr(VI) (Fig. 12).  
Conversely, about 12% or 14% of polη foci localized to telomeres after 10J/m2 UVC or 3 
μM Cr(VI), respectively.  Given that telomeres comprise less than 0.025% of the 
genome, we propose this represents a striking TLS response. 
2.5.3 Polη Suppression of DDR at Telomeres after Bulky Lesion Production 
Signaling of the DSB damage response (DDR) at telomeres may signify DSB formation 
and/or unprotected and dysfunctional telomeres.  The DDR is normally suppressed at 
functioning telomeres, but is activated when telomeres are deprotected upon loss of 
structure or the shelterin complex (Takai et al., 2003).  Unprotected telomeres are 
vulnerable to inappropriate DNA repair and chromosome fusions because they are 
physically similar to DSBs (Palm and de Lange, 2008).  DDR also occurs when stalled 
forks collapse into DSBs (de Feraudy et al., 2010; Limoli et al., 2002), which may cause 
telomere loss based on reports that DSBs are not repaired at telomeres (Fumagalli et 
al., 2012).  XPV cells show more cells with γH2AX foci after UV, hydroxyurea, and 
psoralens, and increased activation of ATR after UV (Bomgarden et al., 2006; de 
Feraudy et al., 2007; de Feraudy et al., 2010; Mogi et al., 2008).  In agreement with 
these reports we found polη suppresses global DDR and decreased DDR at telomeres 
after UVC and Cr(VI) (Fig. 15).  We propose the telomeric DDR arise from replication 
fork demise at telomeres because we and others showed γH2AX foci formation 
following UVC and Cr(VI) depend on S-phase progression (Ha et al., 2004; Limoli et al., 
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2002; Liu et al., 2010; Squires et al., 2004; Zecevic et al., 2009).  In contrast, DDR at 
telomeres due to shelterin loss does not depend on cell cycle (Konishi and de Lange, 
2008), and the UVC and Cr(VI) lesions frequency is unlikely to be high enough to 
displace significant shelterin. 
 
Consistent with previous reports (Harrigan et al., 2011; Lukas et al., 2011), we 
observed two types of 53BP1 formations; small foci or large bodies.  Small foci are 
typically more abundant than the large bodies and were found to occur during S-phase 
(Harrigan et al., 2011).  While our analyses included both variations of 53BP1 foci, we 
observed the vast majority were smaller foci rather than larger bodies. Both types of 
formations indiscriminately co-localized to γH2AX (data not shown).  Moreover, the 
pattern of small 53BP1 foci we observed after UVC and Cr(VI) resembled those formed 
after aphidicolin treatment or loss of shelterin protein, which causes foci formation and 
fork stalling at telomeres (Sfeir et al., 2009). 
2.5.4 Polη Suppression of Telomere Aberrations Caused by Bulky Lesion 
Production 
Telomere losses and telomere doublets have been reported as consequences of 
replication fork stalling at telomeres (Sfeir et al., 2009; Suram et al., 2012).  Telomere 
losses, or critically short telomeres, are proposed to arise from telomeric breaks that 
occur in response to collapsed forks (Crabbe et al., 2004).  Doublets are also termed 
fragile telomeres because they arise upon cellular treatments that induce breaks at 
common fragile site sequences (McNees et al., 2010; Sfeir et al., 2009).  The molecular 
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nature of telomere doublets remains unknown, but they are proposed to represent 
aberrantly condense chromatin due to regions of unreplicated ssDNA (Sfeir et al., 
2009).  We found the generation of replication blocking lesions also causes both forms 
of telomere aberrations and is significantly enhanced in cells lacking polη (Fig. 16).  This 
suggests that lesion bypass by polη resolves replication blocks at telomeres, thereby 
suppressing breaks and accumulation of ssDNA or aberrant replication intermediates.  
Notably, the stabilization of blocking G-quadruplex structures at telomeres also induces 
both telomere loss and doublets (Rizzo et al., 2009).  We see an average of two 
telomere losses and doublets per metaphase after UVC and 2-5 telomeres losses and 
doublets after Cr(VI) (Fig. 16).  Several factors influence detections of telomere 
aberrations.  1) Measuring telomere aberrations on metaphase chromosomes requires 
cell cycle progression.  Therefore, the aberrations in XPV cells may be underestimated 
due to the increased S-phase delay in polη deficient cells after genotoxic exposures 
(Fig. 10).  2) Both unrepaired replication forks and dysfunctional telomeres can activate 
p53-mediated G2 checkpoints and prevent progression to mitosis (Cordeiro-Stone et al., 
2002; Thanasoula et al., 2012).  Previous reports indicate that SV40-transformed XPV 
fibroblasts are more sensitive to UV and show more UV-induced sister chromatid 
breaks compared to primary cells due to large T-antigen suppression of p53 (Cordeiro-
Stone et al., 2002).  Consistent with this, we observed fewer UV-induced chromatid 
breaks in primary cells, and fewer UV-induced telomere loss in the primary BJ cells (Fig. 
17).  Since detection of telomere loss and doublets occurs when checkpoints fail to 
prevent cell progression to metaphase, they may be more apparent in p53 defective 
cells (Karlseder et al., 1999).   
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One possibility is that telomere aberrations result from global DNA synthesis 
inhibition due to signaling from stalled forks elsewhere in the genome, rather than due 
to stalled forks at telomeric DNA lesions.  We do not favor this model for several 
reasons.  First, low level chronic Cr(VI) exposures caused a modest decrease in cells 
replicating DNA compared to UVC (Fig. 10), yet Cr(VI) induces more telomere 
aberrations and DDR positive telomeres (Fig. 16 and 15, respectively).  Second, we and 
others have demonstrated that UV photoproducts form at telomeres following UV 
irradiation (unpublished data) (Kruk et al., 1995; Rochette and Brash, 2010).  Third, 
previous studies reported that UV irradiation with a porous filter resulted in ATR and 
polη staining only at sites of UV-induced lesions (Kannouche et al., 2001; Volker et al., 
2001; Ward et al., 2004), suggesting that UVC irradiation does not induce replication 
stress at sites lacking DNA lesions.  Finally, if the telomere aberrations are caused by 
global DNA replication inhibition and not lesions at the telomeres, then we would expect 
the level of UVC and Cr(VI)-induced aberrant telomeres to be higher and more similar to 
aphidicolin treatment after which every telomere is affected (Sfeir et al., 2009).  If 
individual lesions are causing the replication stress that leads to telomere defects, then 
only those telomeres with a lesion should be affected, and we would not expect every 
telomere would harbor blocking lesions.  Lesion generation is random and stochastic.  
Aphidicolin affects all replication forks because the DNA polymerase is inhibited.  
Importantly, some telomeres with a lesion might be bypassed by other than TLS 
polymerases, such as polymerase ι or polymerase ζ (Sale et al., 2012). 
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2.5.5 Roles for Polη in Preserving Telomeres in the Absence of Exogenous 
Damage 
The telomere aberration analysis also revealed that untreated XPV cells show an 
increase in telomere losses and doublets compared to untreated Wt cells (Fig. 16).  The 
difference for losses and doublets is significant for both the mock untreated samples in 
both the UVC and Cr(VI) experiments (Student’s t-test, p<0.05).  Other studies have 
demonstrated that telomere doublets and aberrations result from endogenous damage.  
Both telomere losses and doublets were reported in cells lacking glycosylases that 
remove 8-oxo-guanine and oxidized pyrimidines (Vallabhaneni et al., 2013; Wang et al., 
2010) and that harbor unresolved G-quadruplexes (Rizzo et al., 2009).  Previous 
studies report polη bypasses 8-oxoguanine and thymine glycol lesions (Chen et al., 
2006) demonstrating the importance of polη in cells experiencing endogenous damage.  
Furthermore, polη deficient cells are hypersensitive to ligands that stabile G-quadruplex 
structures which can form in telomeric DNA (Betous et al., 2009).  Combined with these 
previous studies, our work suggests that polη has a role at telomeres even at sites of 
endogenous lesions emphasizing polη as a requirement for telomere maintenance. 
2.5.6 Biological Implications 
Our study reveals the novel finding that polη protects against telomere defects after 
both an acute physical (UVC) and chronic chemical (Cr(VI)) exposure, and this role 
likely extends the induction of bulky lesions from other sources capable of causing 
replication stress (Chen et al., 2006).  Based on reports that telomeres lack robust DNA 
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repair mechanisms compared to the rest of the genome (Fumagalli et al., 2012; Kruk et 
al., 1995; Palm and de Lange, 2008; Rochette and Brash, 2010), our data supports the 
model that telomeres, in particular, may rely heavily on TLS to avoid the consequences 
of replication fork collapse (i.e. DSB formation).  Our data also uncover new evidence 
that UVC irradiation can induce telomere loss and fragility.  This is significant in light of 
new studies that classify UV irradiation as an environmental geratogen based on 
evidence that UV exposure induces cell senescence in irradiated p16-reporter mice 
(Sorrentino et al., 2014).  Our findings provide evidence that UV light and the 
consequent DNA photoproducts may promote senescence and aging in part by 
disrupting telomeres that harbor the lesions. 
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3.0  FINAL DISCUSSION 
3.1 Summary of Findings 
The research herein advances our knowledge of DNA damage response mechanisms 
at telomeres and DNA damage response mechanisms to an important environmentally 
hazardous metal, Cr(VI).  We have made three principle and novel discoveries in the 
field.  1) UV irradiation induces telomere aberrations associated with replication stress.  
2) Polη protects against Cr(VI)-induced cytotoxicity and replication stress.  3) Polη, in all 
probability through TLS, is required for proper replication of telomeres after the 
induction of bulky DNA lesions. 
3.2 Cr(VI)-Induced Replication Stalling Lesions 
Lesions induced by Cr(VI) include DNA adducts, DNA strand breaks, DNA-protein 
crosslinks, oxidized bases, abasic sites, and DNA intra- and interstrand crosslinks 
(O'Brien et al., 2003).  Of these, interstrand crosslinks, oxidized bases, and Cr(III)-DNA 
adducts mediated by cysteine reduction have been implicated in arresting DNA 
replication polymerases (reviewed in (O'Brien et al., 2003)).  Binary Cr(III)-DNA adducts 
to phosphates develop into ternary adducts, of which DNA crosslinks involving 
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glutathione, cysteine, or ascorbate were initially believed to be the most common until 
very recent findings (Quievryn et al., 2002; Zhitkovich et al., 2001).  Cr-DNA crosslinks 
were shown to be mutagenic and inhibit replication of Cr-exposed shuttle vectors in 
human cells (Quievryn et al., 2003; Voitkun et al., 1998).  Cr(VI) reactions with 
ascorbate and cysteine formed DNA interstrand crosslinks in vitro (Bridgewater et al., 
1994a; Flores and Perez, 1999; Zhitkovich et al., 2000) but glutathione did not (O'Brien 
et al., 2001).  Importantly, glutathione is the main reducer available for Cr(VI) 
metabolism in cell culture medium (Morse et al., 2013).  In cell culture medium 
supplemented with ascorbate, 1-2% of ascorbate-chromium reactions resulted in 
interstrand crosslinks, which were insufficient to cause Cr(VI) hypersensitivity in cell 
lines deficient in crosslink repair, specifically cells lacking FANCD2 or XPF-ERCCI 
(Morse et al., 2013).  Previous studies have identified a role for polη in response to 
interstrand crosslinks (Ho and Scharer, 2010; Mogi et al., 2008; Zheng et al., 2003).  In 
these studies, polη was proposed to partner with NER or XPF-ERCCI to fill in the single 
strand gaps created by removal of the crosslink.  Although recent data suggest 
interstrand crosslinks are unlikely to be a major contributor to Cr(VI)-induced 
genotoxicity, replication stalling caused by just a few crosslinks may nevertheless 
require polη for efficient recovery. 
 
As in the case of UV dimer removal, NER was reported to mediate the efficient 
removal and rapid repair of Cr(III)-DNA adducts that modestly distort the DNA helix 
(Reynolds et al., 2004).  This study also reported a remarkably fast repair rate of about 
50,000 lesions/min/cell in human fibroblasts by NER, reflecting an adduct population of 
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20-25 Cr(III)-adducts/104 DNA base pairs (Reynolds et al., 2004).  Moreover, they 
observed a 10-fold increase in mutagenesis in cells deficient in NER after Cr(VI) 
exposure.  Indeed, no study to date has excluded Cr(III)-DNA adducts as possible 
replication blocking adducts.  In fact, Zhitkovich et al. showed that Cr(VI) reduction by 
cysteine formed lesions on pSP189 shuttle-vector that interfered with replication in 
human fibroblasts (Zhitkovich et al., 2002).  In this investigation, Cr(VI) generated 54% 
and 45% of binary and ternary DNA adducts respectively, accounting for the majority of 
Cr(VI)-induced lesions (Zhitkovich et al., 2002) and implicating these lesions as the 
most likely replication stalling adducts. 
3.3 Theoretical Lesion Estimation at Telomeres 
The estimation of binary and ternary Cr(III)-adducts cited above, 20-25 Cr(III)-
adducts/104 DNA base pairs, is based on a 5 μM Cr(VI) exposure for three hours of 
human fibroblasts (IMR90 cells) (Reynolds et al., 2004).  Although we used a slightly 
lower concentration, 3 μM Cr(VI), based on this study we can roughly estimate how 
many replication blocking lesions we would expect at the telomeres following Cr(VI) 
exposure.  Since healthy human telomeres are estimated to be around 10 kb, we may 
expect every telomere to be affected, exhibiting between 20-25 Cr(III)-adducts per 
telomere.  Normal interphase cells have 46 chromosomes and 92 telomeres.  
Consequently, we can predict that between 1840-2300 Cr(III)-adducts would form at 
telomeres.  There are 92 sister chromatids in metaphase and thus 184 telomeres.  In 
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theory, metaphase chromosome spreads could have between 3680-4600 Cr(III)-
adducts at the telomeres.   
 
UVC-induced dimers were reported to be about 1 CPD/1.3x105 basepairs/Jm2 
(Mitchell, 1988).  If telomeres are on average 10 kb long, then in contrast to the Cr(VI) 
exposure, we would not expect that every telomere would harbor a UV-dimer after the 
10 J/m2 exposure study.  Rather, we estimate about 1 CPD/13 telomeres.  In interphase 
cells with 92 telomeres, we would expect about 7 total CPDs at telomeres per cell.  At 
metaphase, with 184 telomeres we would expect about 14 total telomeric CPDs per cell. 
 
Although the theoretical number of lesions is much closer to our study results for 
UVC than for Cr(VI), neither estimation corresponds to the number of telomeric sites of 
replication stress, telomeric polη foci, or telomere aberrations quantified in our study for 
either UVC or Cr(VI).  We report 2-3 ATR foci at telomeres after UVC and 6-7 ATR foci 
at telomeres after Cr(VI) (Fig. 11).  About 2-3 polη foci localize to telomeres following 
both UVC and Cr(VI) exposure (Fig. 12).  About 2 signal free ends and 2 doublets were 
identified following UVC in XPV cells (Fig. 16C) and 2-5 signal free ends and doublets 
were detected following Cr(VI) exposure in XPV cells (Fig. 16D).  There are several 
possible explanations for the lower levels of telomeric replication stress and aberrations 
compared to the estimated number of adducts at each telomere following the exposure.  
First, the amount of adducts reported for both UV and Cr(VI) exposure is based on data 
for genomic DNA.  Telomeric DNA may be shielded by the shelterin complex which may 
offer some degree of protection against the formation of lesions.  Second, our 
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microscopy confocal images represent a snapshot in time and only one focal plane of 
view (one z-slice is 300 nm at a pinhole of one airy unit).  Third, multiple cellular events 
must coincide in order for a replication fork to stall or a telomere aberration to occur.  
Regarding polη foci formation, the replication fork must be present at the site of a lesion 
at the time the cell is processed for analysis.  Fourth, alternative TLS polymerases may 
be recruited to some lesion sites, which could prevent persistent fork stalling and 
subsequent telomere aberrations.  It is also worth noting that telomere aberrations on 
metaphase chromosomes can only be detected in those cells that bypass checkpoints 
and proceed through S-phase to metaphase.  Finally, every lesion at the telomere may 
not lead to replication stress.   
3.4 Werner Syndrome Protein Interaction with Polymerase η 
Of noteworthy importance, Werner Syndrome Protein (WRN) has been implicated in 
mediating polη efficiency and fidelity of DNA synthesis (Maddukuri et al., 2012).  TLS 
polymerases lack the proofreading ability that replicative polymerases possess which 
contribute to decreased fidelity during DNA synthesis by a TLS polymerase (Friedberg, 
2005; Prakash et al., 2005).  WRN is endowed with exonuclease activity capable of 
proofreading base pairs that polη incorporates opposite DNA lesions or on undamaged 
DNA templates.  We previously reported that WRN contributes to the maintenance of 
telomere integrity after Cr(VI) exposure of human cells (Liu et al., 2010).  If WRN 
suppresses the formation of telomere aberrations at sites of replication stress caused by 
Cr-DNA adducts, it is reasonable to predict that WRN may also function to suppress 
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deleterious events at UVC-induced CPDs or 6-4 PPs.  Moreover, WRN may cooperate 
with polη to prevent replication fork stalling at telomeres.  Taken together, these studies 
support the model that telomere loss is caused by failures in telomere replication.   
3.5 Study Limitations and Future Directions 
3.5.1 Evidence of Replication Stress 
ATR is an important checkpoint protein kinase and has been shown to respond to a 
stalled replication fork, particularly at the single-stranded DNA intermediate (Abraham, 
2001).  Previous studies demonstrate that UV (Despras et al., 2010; Heffernan et al., 
2002) and Cr(VI) (Wakeman and Xu, 2006) exposure activate ATR as part of the S-
phase checkpoint response.  We showed ATR foci formation after exposure to UVC and 
Cr(VI) in human U2OS cells (Fig. 11).  Furthermore, we showed that ATR foci form at 
telomeres after these genotoxic agents.  To our knowledge, this study represents the 
first demonstration of ATR foci formation at telomeres.  However, while ATR foci 
formation suggest ATR activation, visibility of foci is not direct evidence of protein 
function or kinase activity.  Indeed, a mutant of polη harboring a mutation in a 
phosphorylation site, S601, still formed visible foci, even though the protein was not fully 
functional (Gohler et al., 2011).  On the contrary, a mutant form of Rad18 was observed 
function in DNA damage tolerance pathways in spite of its inability to form foci 
(Nakajima et al., 2006).  Evidence of replication stress could be further strengthened in 
our study through protein analysis of downstream targets of ATR activation, namely 
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Chk1 phosphorylation.  Chk1 is a well-established marker for checkpoint activation in 
response to replication stress (Smits, 2006).   
 
As further evidence for out model that polη suppresses persistent replication fork 
stalling after UV and Cr(VI), we expect that ATR foci formation would be increased in 
polη deficient cells compared to wild type cells.  To test this in future studies we could 
use isogenic XPV and Wt cells and immunofluorescene-fluorescence in situ 
hybridization (IF-FISH) analysis to stain for phosphorylated forms of ATR and Chk1 at 
telomeres following UVC or Cr(VI) exposure.  Göhler et al. reported that ATR 
phosphorylated polη after UV exposure (Gohler et al., 2011), suggesting a direct 
interaction between ATR and polη.  Protein-protein interactions could be examined 
through co-immunoprecipitation of polη and ATR after UVC and Cr(VI).   
 
In the future, to further characterize protein interactions with telomeric DNA, we 
could use chromatin immuno-precipitation (ChIP).  Mammalian telomeres are bound by 
the shelterin protein complex which functions to prevent telomeres from being 
recognized as DNA double strand breaks (de Lange, 2005).  Replication fork stalling at 
telomeres in XPV and Wt cells could be examined directly by the incorporation of BrdU 
analogs to mark replicating DNA concurrently with ChIP (Rizzo et al., 2009).  Briefly, 
UVC and Cr(VI) exposed cells synchronized at the G1/S phase are incubated with BrdU 
prior to harvesting at various time points through cell cycle progression.  DNA-bound 
proteins are cross-linked to the genome and chromatin is fragmented by sonication.  
The protein-bound telomeric DNA is isolated by precipitation with antibodies against 
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shelterin proteins, TRF1, TRF2, and POT1.  Proteins are released by reversing the 
cross-links and the fraction of replicating telomeric DNA is evaluated by western blotting 
with an antibody that recognizes the BrdU analogs incorporated into the newly 
synthesized daughter strand.  If replication forks are stalled at telomeres after UVC and 
Cr(VI) exposures in XPV cells, then we would expect fewer XPV cells would show BrdU 
incorporation in the telomeric DNA compared to Wt due to their reduced capacity to 
bypass blocking lesions.  However, the low number of telomeric ATR foci per cell (Fig. 
11); with the low abundance of telomeric DNA (less than 0.025% of the genome), 
suggest that this ChIP assay may not be sensitive enough to detect fork stalling at 
telomeres in our study.  Furthermore, as noted earlier, the frequency of UV-induced 
lesions at telomeres is low, and suggests that not every telomere would harbor a 
replication-blocking lesion after UV.  
3.5.2 Cr(VI)-Adducts and Replication Stress 
The formation of UV-dimers at telomeres has been demonstrated previously (Kruk et 
al., 1995; Rochette and Brash, 2010).  Cr(VI) on the other hand, is known to induce 
bulky lesions capable of stalling replication forks, but Cr(VI)-induced bulky lesion 
formation has not been investigated or measured at telomeres.  Inductively-coupled 
plasma mass spectrometry (ICPMS) is a highly sensitive method to measure Cr-DNA 
binding and can be applied to Cr(VI) exposures in cell culture.  Following Cr(VI) 
exposure, cells are washed and harvested.  DNA is isolated and digested at 
subtelomeric regions, followed by purification of the telomeric fragments.  ICPMS is then 
used to measure Cr-telomeric DNA adducts.  If the Cr-telomeric DNA adducts are too 
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few and below the detection limit of ICPMS, 51Cr-labeled Cr(III) can be converted to 
51Cr-labeled dichromate and exposed to cells in culture.  Cells are then harvested, DNA 
is isolated and digested at subtelomeric regions to separate genomic from telomeric 
DNA.  The DNA is then loaded onto an electrophoresis gel for detection of the 
radioactive isotope. 
 
Further evidence of replication fork stalling at telomeric Cr-adducts could be 
obtained through the use of single molecule analysis of replicated DNA (SMARD).  
SMARD uses two halogenated nucleoside analogs that are incorporated into replicating 
DNA; one analog is incorporated first for about 2-4 hours followed by incorporation of 
the second analog for an additional 2-4 hours.  DNA fibers are stretched and stained 
with fluorophore-conjugated antibodies against these analogs making them visible 
under a fluorescent microscope.  SMARD can detect various replication events 
including progression, stalling, and termination by comparing the staining patterns of 
nucleotide analog 1 and analog 2.  This assay can be specific to telomeric DNA fibers 
by using restriction enzyme digests to release subtelomeric and telomeric fragments, 
and by annealing PNA-probes that bind the telomeric and subtelomeric DNA sequences 
(Sfeir et al., 2009).  Prior to SMARD, we would examine and compare the kinetics of 
Cr(VI) uptake in the XPV and control cells.  The analysis of cellular Cr(VI) uptake 
involves a rather straightforward process of harvesting Cr(VI) treated cells in the 
presence of ethylenediaminetetraacetic acid (EDTA) and measuring Cr concentration by 
atomic absorption spectrometer, as described previously (Morse et al., 2013).  Once the 
kinetics of Cr(VI) is known, Cr(VI)-treated and untreated XPV and control cells would be 
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processed for SMARD, and direct detection of replication patterns would be compared 
between the different conditions and cell types.  Since the kinetics of Cr(VI) uptake is 
known and would be used to determine the length of Cr(VI) exposure, this experiment 
will provide evidence based on initial Cr(VI) genotoxic activity and identification of early 
products of Cr(VI) exposure as opposed to accumulated toxic cellular activity.  
Addressing initial Cr(VI) adduct formation will help determine whether the replication 
events were directly due to Cr(VI), rather than indirectly due to global Cr(VI)-induced 
cellular stress. 
3.5.3 Polymerase η Functions at Telomeres after Exposure to Genotoxic Agents 
We demonstrated that polη localizes to telomeres and we showed that telomere defects 
increase in the absence of polη following UV and Cr(VI) exposures, but further studies 
are needed to establish polη’s precise role at telomeres.  While mutagenesis assays 
have been done previously in polη deficient cells exposed to UV (Stary et al., 2003), 
mutagenesis rates at telomeric DNA is not known and mutagenesis rates after Cr(VI) 
exposure of mammalian cells is not known.  Comparison of mutation frequencies 
between UVC- or Cr(VI)-treated and untreated shuttle vectors (SVs) containing 
telomeric DNA, replicated in either Wt or XPV cells would provide evidence regarding 
polη’s role in suppressing the formation of mutations at telomeric and non-telomeric 
DNA sequences.  Although SVs containing telomeric DNA are not equivalent to intact 
telomeres in structure or chromatin assembly, SVs are able to demonstrate polη’s 
potential role in suppressing the formation of mutations in telomeric DNA sequences.  
We would expect that the replication of UVC exposed SVs in XPV cells would result in 
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more mutations, compared to Wt cells, at the SV telomeric and non-telomeric 
sequences, based on previous report for to genomic DNA (Stary et al., 2003).  
However, it is worth noting that the traditional SV mutagenesis assays only allow for the 
identification of mutations in a reporter gene.  Therefore, the identification of telomeric 
DNA mutations would require DNA sequencing of all the SV that were replicated in, and 
isolated from, human cells.  This could potentially be achieved using Next Generation 
Sequencing approaches.  Specifically in the case of Cr(VI), if polη is accurately 
bypassing Cr(VI)-induced lesions, then Cr(VI) exposed SVs should show more 
mutations after replication in the XPV cells compared to the Wt cells.   
 
Our studies indicate that polη forms foci after Cr(VI) exposure in human cells 
(Fig. 12), but whether polη accurately bypassing Cr(VI)-induced adducts in these cells is 
unknown. To address this, we began a study using the supF shuttle vector (SV) 
mutagenesis assay (Fig. 18).  This assay uses the pSP189 SV with the tyrosine amber 
suppressor tRNA supF reporter gene.  Our study design originally planned to compare 
SV containing six telomeric repeats that were either mock exposed or exposed to Cr(VI) 
in vitro.  The telomeric repeats are adjacent to the supF reporter gene, therefore, while 
base substitutions within the telomeric repeats are not detectable, deletions and 
rearrangements within the telomeric repeats that also impact the reporter gene are 
detectable.  However, our study was not completed and the colonies reflecting 
mutagenesis events were not sequenced.  Therefore, specific types of mutations after 
Cr(VI) exposure in cells lacking functional polη that are normally detectable by this 
assay, are not reported.  However, we obtained preliminary supF mutation frequencies 
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(see Appendix, Fig. 19).  The supF tRNA inserts a tyrosine at UAG stop codon in a 
mutant lacZ gene and restores β-galactosidase activity in the MBM7070 bacteria strain.  
This protein converts X-gal to a blue color product called 5,5’ –dibromo-4’4-dichloro-
indigo (DBDCI).  Wild type supF bacteria colonies are blue and mutant colonies are 
white in X-gal media.  The SV contains an SV-40 origin of replication.  First, we exposed 
the SV to 100 μM Cr(VI) and the dominant reducer of Cr(VI), ascorbate (Standeven and 
Wetterhahn, 1992), in vitro for 30 minutes.  Cr(VI)-treated SVs were then transfected 
into human cells.  U2OS cells stably expressing either a control shRNA against GFP 
(Control) or an shRNA targeted against polη (shPolη) (Appendix, Fig. 19B) were used to 
replicate the Cr(VI)-treated SV.  Cells were allowed to replicate the SV for 48 h before 
isolating the SV and transfecting them into the E. coli reporter MBM7070 cells for the 
identification of colonies harboring inactivating supF SV mutations.  We observed a 1.5 
fold increase in Cr(VI)-treated SV mutation frequency in shPolη cells compared to 
control cells.  Therefore, our preliminary data suggests that, similar to yeast, polη is able 
to accurately synthesize past Cr(VI)-induced adducts (Appendix, Fig. 19).  Future 
studies will require comparisons of mutation frequencies for untreated SVs after 
replication in polη deficient cells compared to Wt cells, as well as comparisons at 
various Cr(VI) concentrations.  However, previous reports have shown that untreated 
XPV cells do not exhibit a higher level of spontaneous genomic mutations compared to 






(A) Shuttle vector (SV) plasmids harboring supF, a suppressor tyrosyl tRNA gene, are 
incubated with Cr(VI) and transfected in cells for replication.  (B) SV replicates are 
isolated and transfected into bacteria engineered with lacZ amber mutations.  (C) Cells 
that contain non-mutated plasmid generate blue colonies via the lacZ protein product, β-
gal, on X-gal-treated agar plates.  Cells that contain mutations on the plasmid generate 
white colonies because they lack the ability to suppress the mutation in lacZ. 
 




3.5.4 Telomeres with Mutation Accumulation. What’s Next? 
If TLS polη functions at telomeres after Cr(VI)-induced bulky lesions and if TLS polη is 
error-prone, what are the consequences of mutation accumulation at telomeres.  
Whether NER can access the telomeres and repair damaged telomeric DNA is currently 
a topic of debate (Fumagalli et al., 2012; Kruk et al., 1995; Rochette and Brash, 2010).  
On-going studies in the Opresko Laboratory are currently addressing this question.  
Studies have shown that NER can remove lesions left behind following TLS.  Telomeres 
are transcribed into long non-coding RNA, called TERRA (Telomeric Repeat containing 
RNA) (Feuerhahn et al., 2010).  Examination of the consequences of mutant TERRA 
transcripts would shed light on the potential effects of the accumulation of mutations at 
telomeres. 
 
3.5.5 Apoptosis, Senescence, or Carcinogenesis 
We observed that cellular exposures to 10 J/m2 of UVC and 3 μM Cr(VI) led to a 
decrease in the fraction of cells actively incorporating EdU up to 24 h of recovery after 
the exposures (Fig. 10).  Our cytotoxicity study indicates that the majority of Wt and 
XPV cells are alive at 48 h recovery (Fig. 9).  Yet whether these cells eventually 
recover, are permanently arrested and become senescent, or become unstable and 
transform into cancer cells is unknown.  In human fibroblasts, critically short telomeres 
lead to cellular senescence (d'Adda di Fagagna et al., 2003).  We report ATR foci 
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formation after UVC and Cr(VI) exposure (Fig. 11).  However, ATR has a dual role in 
DNA repair and apoptosis (Bernstein et al., 2002).  The pathway for DNA repair 
includes many proteins such as BRCA1, p53, hChk1, and causes cell cycle arrest. The 
pathway for apoptosis includes BRCA1 and p53 (reviewed in (Bernstein et al., 2002)).  
To investigate apoptotic, senescent, or carcinogenic endpoints, experiments would 
need to include time points beyond 24 h recovery after UVC and Cr(VI) exposure.  
Testing for endpoints further downstream of telomere aberrations would improve our 
understanding of the importance of TLS after genotoxic agents at telomeres.   
3.6 BIOLOGICAL IMPLICATIONS 
DNA damage tolerance is a basic biological function that ensures successful 
progression of stalled replication forks.  However, DNA damage tolerance is not always 
error-free, due to the low fidelity of TLS polymerase.  If replication blocking lesions are 
not repaired and are inaccurately bypassed by TLS polymerases, this can cause a 
mutation.  Multiple studies have uncovered roles for TLS polη beyond the bypass of UV 
dimers (reviewed in Chapter 1), but not all report the efficient or accurate bypass that 
occurs between polη and CPDs.  Indeed, polη has probably evolved a specialized role 
in CPD bypass because DNA damage from solar light is as ancient as DNA itself.  The 
ability of polη to bypass other types of DNA damage, including Cr(VI)-induced lesions, is 
probably due to polη’s relatively loose catalytic active site based on X-ray crystal 
structure data (Trincao et al., 2001).  However, our study observed preliminary evidence 
that polη suppresses Cr(VI)-induced mutagenesis and that polη has a critical role in 
 101 
preserving telomeres.  Taken together with reports that polη suppresses Cr(VI)-induced 
mutagenesis in yeast, our studies emphasizes that polη TLS could contribute to the 
protection from human respiratory disease and cancer due to Cr(VI) exposure. 
 
XP patients are characterized by an increase in genomic mutations and high 
rates of skin cancers due to UV exposure (Friedberg et al., 2006).  Although NER is 
active in XPV patients, normal cells utilize both NER and TLS to efficiently recover from 
UV-induced lesions.  As discussed previously, polη is highly regulated and not believed 
to typically function at undamaged DNA except during somatic hypermutation (Waters 
et al., 2009).  We have identified an increased incidence of telomere aberrations in XPV 
patient cells after UVC and Cr(VI) exposures, compared to normal cells.  Telomere 
aberrations can lead to cellular senescence or cancer.  XPV patients show an increased 
incidence in skin cancer after UV exposure and are characterized by premature aging of 
the skin after sunlight exposure.  Therefore, the identification of telomere defects could 
serve as potential biomarkers of pre-malignant or malignant skin cancer lesions after 
UV exposures in XPV patients.  Beyond XPV patients, the early identification of 
telomere aberrations after genotoxic exposures could be useful in detecting deficiencies 
in DNA damage response mechanisms, or in detecting pre-malignant skin lesions since 
telomere alterations can drive carcinogenesis.  The manifestation of telomere 
aberrations in XPV cells as a result of two ubiquitous environmental genotoxicants, UVC 
or Cr(VI), illustrates the special value of polη’s role in preserving chromosomal integrity.  
Polη not only ensures replication fork progression, it creates another opportunity for the 
cell to properly repair the DNA damage following replication.  Polη works to preserve 
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telomere integrity and ultimately, defend the cell from genome instability, senescence, 
or carcinogenesis.  Preventative interventions aimed at telomere preservation following 
exposure to environmental genotoxicants, could potentially inhibit or delay the onset of 
diseases and pathologies that are promoted by telomere defects.   
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APPENDIX: PRELIMINARY STUDY 
EVIDENCE THAT POLYMERASE Η DELETION INCREASES THE MUTATION 
FREQUENCY AFTER CR(VI) EXPOSURE – A PRELIMINARY STUDY 
O’Brien et al. showed that polη was protective against Cr(VI)-induced mutations in S. 
cerevisiae, suggesting that polη was accurately bypassing Cr(VI)-induced DNA adducts 
(O'Brien et al., 2009).  Given our studies indicating polη foci formation after Cr(VI) 
exposure in human cells (Fig. 12), we asked whether polη was accurately bypassing 
Cr(VI)-induced adducts in these cells.  To address this, we employed the supF shuttle 
vector (SV) mutagenesis assay (described in section 3.5.3, Fig. 18).  Our study 
originally planned to compare mutation frequencies of untreated and Cr(VI)-treated SVs 
replicated in polη proficient and deficient cells.  However, recovery of the untreated SV 
was not successful.  Therefore, we only report mutagenesis data for the Cr(VI) treated 
SV.  First, we exposed the SV to 100 μM Cr(VI) and the dominant reducer of Cr(VI), 
ascorbate (Standeven and Wetterhahn, 1992), in vitro for 30 minutes.  Cr(VI)-treated 
and untreated control SVs were then transfected into human cells.  U2OS cells stably 
expressing either a control shRNA against GFP (Control) or an shRNA targeted against 
polη (shPolη) (Fig. 19B) were used to replicate the Cr(VI)-treated SV.  Cells were 
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allowed to replicate the SV for 48 h before isolating the SV and transfecting them into 
the E. coli reporter MBM7070 cells for the identification of colonies harboring 
inactivating supF SV mutations.  We observed a 1.5 fold induction in mutation frequency 
in shPolη cells compared to controls for the Cr(VI) treated SVs (Fig. 19A).  Our data 





(A) Mutagenesis was examined by propagating pSP189 plasmids in U2OS polη KD and 
control cells.  The number of supF mutants and the yield of replicated progeny were 
scored in the E. coli MBM7070 strain.  Data indicate the fold induction between Cr(VI)-
treated vectors replicated in control cells compared to shPolη cells from two 
independent experiments. (B) Western blot shows polη protein levels in U2OS cells 
stably expressing controls or polη shRNAs. 
 
Figure 19. Polymerase η depletion increases the supF mutant frequency of 
Cr(VI) exposure vectors. 
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A.1 MATERIALS AND METHODS 
A.1.1 Cell Culture 
Human U2OS osteosarcoma cells were obtained from ATCC (Manassas, VA).  U2OS 
cells proficient and deficient for polη were generated by stably expressing short hairpin 
RNA (shRNA) against GFP (Control) and shRNA against polη (shPolη).  We obtained 
five lentiviruses from the University of Pittsburgh Cancer Institute Lentiviral Core that 
express an shRNA against polη (MISSION® shRNA, Sigma) and a control lentivirus 
(shRNA against GFP).  Stable clones were obtained by lentiviral transduction and 
selection by culturing in the presence of puromycin (500 ng/ml).  Cells were cultured in 
Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS) and penicillin (50 units/ml), and streptomycin (50 units/ml) in humidified chambers 
with 5% CO2 and 20% O2 at 37⁰C.   
 
A.1.2 SupF Mutational Analysis of Telomeric and Control Shuttle Vectors 
The shuttle vector (SV) plasmids, pSP189, harboring supF, a suppressor tyrosly tRNA 
mutagenic reporter gene, was constructed to contain six telomeric repeats as previously 
reported (Damerla, 2012).  The SV was incubated in the presence of 100 μM Cr(VI) and 
1 mM ascorbate for 30 minutes at 37ºC.  Cr-exposed SV and untreated controls were 
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transfected into U2OS polη knock down (KD) cells and controls cells by mixing 2 μg SV 
with 2 x 106 cells in 100 μl of nucleofector kit V solutions and electroporating with the 
Amaxa Nucleofection system (Lonza).  Cells were allowed to replicate in the presence 
of the SV for 48 h in supplemented DMEM media.  SVs were then isolated using 
PureLink Quick Plasmid Miniprep kit (Invirtogen), and digested with DpnI enzyme to 
separate out unreplicated vectors.  Next, purified SV were transfected into Escherichia 
coli MBM7070 strain bacteria that contains the lacZ amber mutant stop codon and 
incubated for 45 minutes at 37ºC.  Cultures were plated on selective media containing 
50 μg/ml chloramphenicol (chlor), 0.12 mg/ml X-gal and 0.3 mg/ml IPTG permitting 
white/blue screening (Wang et al., 2006).  SupF mutant frequency was determined by 
dividing the number of mutant white colonies by the total number of chlor-resistant 
colonies. 
A.1.3 Western Blotting 
To confirm polη depletion by the shRNA against polη, cell lysates were immunoblotted.  
Cells were collected by scraping, and were washed with cold PBS.  Cells were 
resuspended by whole cell lysis buffer (50 mM Tris [pH 7.4], 20 mM NaCl, 1 mM MgCl2, 
0.1% sodium dodecyl sulfate, 50 U/ml benzonase and protease inhibitor cocktail (1 
μg/ml chymostatin, 1 μg/ml pepstatin, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 0.4 μl/ml 
AEBSF).  Lysates were incubated on ice for 30 min and cell debris was centrifuged at 
15,000g for 20 min at 4ºC.  Proteins were separated by SDS-polyacrylamide gel 
electrophoresis and electro-transferred to an immunoblot membrane.  Proteins were 
probed using anti-polη (Sigma Prestige Antibodies HPA006721, 1:2000) or anti-GAPDH 
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(Santa Cruz, 1:1000).  Probes were visualized using horseradish peroxidase-conjudated 
secondary antibodies (1:5000) and enhanced chemiluminescent plus (Amersham 
Biosciences, NJ). 
A.2 POLYMERASE Η SUPPRESSES CR(VI)-INDUCED MUTAGENESIS. A 
DISCUSSION 
XPV, the autosomal recessive genetic disorder, causes an increased frequency of skin 
cancer from sunlight exposure by 1000-fold (Cleaver, 2000; van Steeg and Kraemer, 
1999).  Polη inserts adenines opposite thymine-thymine (T-T) dimers rather efficiently 
(McCulloch et al., 2004).  It is generally accepted that when polη is lacking, other TLS 
polymerases substitute for this role in spite of their decreased fidelity of DNA synthesis 
(Cleaver, 2000; Johnson et al., 2000; Zhu and Zhang, 2003).  However, polη also 
exhibits low fidelity of DNA synthesis on undamaged DNA or while bypassing other 
types of DNA adducts.  For instance, polη showed increased mutagenicity on templates 
containing benzo[a]pyrene adducts, and templates harboring cisplatin cross-linked di-
guanine adducts (Masutani et al., 2000; Zhang et al., 2002).   
 
We found the generation of replication blocking lesions by Cr(VI) also caused an 
increase in the SV supF mutant frequency in cells lacking polη, compared to Wt cells 
(Fig. 19).  This suggests that polη’s role in bypass of Cr(VI)-induced lesions is 
accomplished with a good degree of accuracy, thereby suppressing potential genomic 
instability and carcinogenicity.  In a previous study in yeast, the polymerase ζ homolog 
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rev3, and polη homolog rad30, are both reportedly involved in the response to Cr(VI) 
exposure (O'Brien et al., 2009).  In the absence of rad30, the incidence of mutagenesis 
increased by 2.7-fold.  In the presence of a Wt rad30 gene and the absence of the rev3, 
gene, the incidence of mutations decreased three-fold (O'Brien et al., 2009).  This 
suggests that the Rev3 polymerase contributed to mutagenesis after Cr(VI) exposure, 
but the Rad30 polymerase achieved more accurate bypass comparatively.  We reported 
a 1.5 fold increase in mutation frequency between Cr(VI)-treated vectors replicated in 
cells knocked down for polη expression compared to control cells.  While this 
preliminary result suggests a role for polη following Cr(VI) exposure, the magnitude of 
the difference in mutation frequency between polη proficient and deficient cells was 
lower than expected.  There are several possible reasons for this.  First, from a 
technical standpoint, shRNA gene silencing does not achieve complete depletion of 
targeted gene.  Residual levels of polη are fully functional and may contribute to 
accurate bypass of the Cr-DNA adducts, thus, lowering the mutation frequency.  
Second, while polη knock down cells may be deficient in TLS by polη, these cells are 
still proficient for other mechanisms that are involved in responding to Cr(VI)-induced 
lesions; namely NER (Reynolds et al., 2004) and MMR (Peterson-Roth et al., 2005).  
Perhaps in the absence of polη, the mechanisms are upregulated.  Third, polη is not the 
only TLS polymerase available to respond to replication fork blocking lesions as 
previously mentioned.  While the accuracy of other TLS polymerases in bypass of 
Cr(VI) is completely unknown, they could potentially contribute to successful and 
accurate bypass of Cr(VI)-induced lesions.   
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A notable problem in our study is the lack of mutation frequency data for 
untreated SVs replicated in the polη proficient and deficient cells.  Unfortunately, each 
experimental replicate performed experienced technical problems with regard to the 
untreated SV conditions, and we were unable to recover accurate results.  One could 
argue that the 1.5-fold increase in Cr(VI)-treated SV mutation frequency for polη  
deficient cells, compared to control cells, could also be expected for the untreated SVs, 
suggesting that the mutagenesis difference reflects polη roles in accurately bypassing 
endogenous damage and rather than the Cr(VI)-induced damage.  However, a very 
recent study reported similar background mutation frequencies in unexposed XPV and 
normal human fibroblasts (Herman et al., 2014).  Consistent with this, mice lacking 
functional polη did not exhibit an increased incidence in tumorigenesis when they were 
not exposed to genotoxicants (Lin et al., 2006).  Although it has been shown in vitro that 
bypass by polη on undamaged templates is error-prone (Matsuda et al., 2000), polη’s 
function is believed to be highly regulated against synthesizing DNA at undamaged 
regions in the genome (King et al., 2005; Pavlov et al., 2001; Waters et al., 2009).  
Taken together, our results require further and more complete analysis on the 
mutagenicity of XPV cells after Cr(VI), but provide good evidence that polη bypass 
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